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ABSTRACT
Corynebacterium glutamicum is of huge importance in the production of amino acids
and has an impressive portfolio of substrates and products.
In this thesis it was shown that elevated growth temperature led to decreased
biomass yield and specific growth rate and to increased lysine yield. At 38 ◦C,
the lysine yield was ca. 40-55 % higher than at 30 ◦C. Metabolic flux analysis of
C. glutamicum Lys12 revealed 101 % flux through the pentose phosphate pathway at
38 ◦C, as compared to 86 % at 30 ◦C. In a fed-batch bioreactor setup, the cultivation
at 38 ◦C led to a 10 % higher yield, as compared to 30 ◦C.
Also, C. glutamicum Lys12 was modified to allow for growth and lysine production
from xylose via expression of the Escherichia coli genes xylA and xylB. The resulting
strain C. glutamicum Xyl1 was able to grow at 0.17 h-1 and converted xylose into
lysine at a yield of 0.25 mol mol-1. In a more industry-like fed-batch bioreactor setup
116 g L-1 lysine were produced with a xylose based medium.
Finally, the Pseudomonas stutzeri ectABCD operon (with the osmosensitive promoter
exchanged for a constitutive one and the codon usage of C. glutamicum considered)
was expressed in C. glutamicum lysCT311I to enable ectoine production. This strain
produced ectoine (19 mol mol-1) from glucose, but also lysine, which was stopped
by deletion of lysE. Elevated temperatures led to improved ectoine secretion and
4.5 g L-1 ectoine could be produced in a fed-batch process at 35 ◦C.
x
ZUSAMMENFASSUNG
Corynebacterium glutamicum ist von großer Bedeutung für die Produktion von
Aminosäuren und weist ein beeindruckendes Spektrum an Substraten und Produkten
auf.
In dieser Arbeit wurde gezeigt, dass erhöhte Wachstumstemperaturen zu re-
duzierter Biomasseausbeute und spezifischen Wachstumsrate sowie erhöhter Lys-
inausbeute führten. Bei 38 ◦C lag die Ausbeute ca. 40-55 % höher als bei 30 ◦C.
Metabolische Flussanalyse zeigte 101 % Kohlenstofffluss durch den Pentosephosphat-
weg bei 38 ◦C, während bei 30 ◦C nur 86 % erreicht wurden. In einem Fedbatch
Prozesses im Bioreaktor war die Lysinausbeute bei 38 ◦C 10 % höher als bei 30 ◦C.
Das Einbringen der Escherichia coli Gene xylA und xylB in C. glutamicum Lys12
ermöglichte außerdem Wachstum mit 0,17 h-1 sowie Lysinproduktion mit einer
Ausbeute von 0,25 mol mol-1 auf Xylose. In einem Fedbatch Bioreaktorexperiment
wurden in einem auf Xylose basierten industrienahen Medium 116 g L-1 Lysin
produziert.
Schließlich wurde noch das Pseudomonas stutzeri ectABCD Operon (mit ausget-
auschtem Promotor und berücksichtigter Codonverwendung) in C. glutamicum Lys1
eingebracht, was die Ectoinproduktion von Glukose ermöglichte (19 mmol mol-1).
Die Sekretion des Nebenprodukts Lysin wurde durch Deletion von lysE unterbunden.
Wie bei der Produktion von Lysin führten erhöhte Temperaturen zu einer verbesser-
ten Ectoinproduktion und in einem Fedbatch Bioreaktor konnten bei 35 ◦C 4,5 g L-1
Ectoin produziert werden.
xi
CHAPTER 1
INTRODUCTION
1.1 General introduction
Biotechnology, i.e. ‘any technological application that uses biological systems, living
organisms or derivatives thereof, to make or modify products or processes for specific
use’ [209], has been employed by humans for centuries. Many people are, however,
not aware of the importance of this scientific field for their daily lives, even though
biotechnology comprises a wide range of applications e.g. in the pharmaceutical
or the food industry. The important flavor enhancer glutamic acid falls into the
latter category and is produced on an industrial scale by the microorganism Coryne-
bacterium glutamicum. This organism is closely linked to its most famous product,
glutamate, that it was even named after it.
Fig. 1: Phase contrast microscopic image of
C. glutamicum [22].
C. glutamicum, a Gram-positive rod
shaped microorganism, was isolated in
Japan in the mid 1950s [108] during a
program screening for microorganisms
able to produce glutamic acid. It was
soon discovered that C. glutamicum
is capable of producing other amino
acids besides glutamate, first and fore-
most lysine [107]. Today, C. glutami-
cum is one of the most important mi-
croorganisms for fermentative produc-
tion of amino acids and a workhorse of
industrial biotechnology [15]. C. glu-
1
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tamicum has earned the status as a industrial workhorse and a platform organism
because of its robustness in large scale production processes, proven over many
decades [59].
From early on, the increase of lysine yields and titers were major goals of strain
optimization to enable more efficient production. Initially, this was realized by
random mutagenesis and subsequent selection [98]. More recently, the genome
sequence of C. glutamicum was unraveled [93] and by now systems metabolic engin-
eering provides the possibility for systems-wide understanding of the intracellular
mechanisms of the organism and optimization for improved production [18].
Continuously, this was driven by an increasing demand for lysine throughout the
decades, illustrated in Fig. 2. Lysine, i.e. the biologically active L-enantiomer L-lysine,
is an essential amino acid for most vertebrates and an important feed additive for the
cereal-based fodder of the pig and poultry industry [230]. In such feedstuffs, lysine is
one of the limiting amino acids [246]. Its concentration does not satisfy the demand
of animal mast. Even though nutritional requirements in animals may vary with age
and gender, and despite regional variations in fodder composition, L-lysine is the
first limiting amino acid when breeding pigs and the second limiting in breeding
poultry [94]. This can be visualized using the concept of LIEBIG’S barrel (Fig. 3)
showing that a limitation in one compound can hinder the performance of the entire
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Fig. 2: Worldwide production of L-lysine and poultry in the past decades. Lysine data until
2005 are taken from [163], 2009 data from [46] and later data/predictions from [142].
Poultry data are taken from [210].
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system. Compensation for this limitation by addition of L-lysine leads to higher meat
yield and lower ammonia burden in the manure [46]. The still increasing worldwide
demand for meat predicts an increased lysine market for the future [142].
C. glutamicum is able to naturally utilize a wide range of substrates [125]. This
includes many sugars such as glucose, fructose or sucrose, organic acids like succinate
and lactate [35]. Traditionally, lysine has been produced by fermentation from sugar-
based resources like starch hydrolysates or molasses [102, 238]. Clearly, for the
production of a ‘high-volume low-value ’ product such as lysine, the raw material costs
are a decisive factor for the profitability of a production plant [46]. An additional
downfall of the traditional substrates is a high price volatility [142, 243]. Coupled to
the criticism of using glucose-based, i.e. human consumable resources, to produce
animal feed additives, these points provide a strong incentive for the search for
alternative raw materials.
A promising candidate is the hemicellulose sugar xylose, a major building block
of lignocellulose and widely abundant as a by-product in agriculture and in the
pulp and paper industry [130], i.e. lignocellulosic waste products. The pentose
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Fig. 3: LIEBIG’S barrel as a graphical representation of the nutritional value of lysine as a
animal feed additive.
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is, however, not a natural substrate for most strains of C. glutamicum [59], but
an interesting raw material nevertheless. Turning a waste product into a valuable
commodity chemical is not only of economic interest, but could also help to create a
more ecologically sustainable approach to industrial lysine production [35]. Systems
metabolic engineering has been shown to enable C. glutamicum to utilize xylose for
growth and production by expressing xylulokinase and xylose isomerase from E. coli
and from other microorganisms [36, 138].
With regard to the product portfolio, C. glutamicum is capable of producing a wide
range of chemicals beyond L-amino acids: bulk products such as D-amino acids[196],
diamines [103, 180], organic acids [155, 156] and biofuels like ethanol [82] or
isobutanol [23], among other products [15]. In addition, also high-value chemicals
become accessible through C. glutamicum.
Ectoine is a compatible solute and interesting agent for the pharmaceutical and
cosmetic industry [61, 124, 160]. Ectoine is currently used in products like sunscreen
and nasal spray due to its moisturizing, protective and anti-inflammatory qualities
[204]. The current production relies on a process called ‘bacterial milking’, which is
technically demanding and corrosive for the equipment [120]. Ectoine is not natively
synthesized by C. glutamicum [14]. The biosynthetic route to ectoine starts from
L-aspartate semialdehyde, a precursor of the biosynthetic route towards lysine. This
makes C. glutamicum an excellent starting point for development [14].
Besides the molecular set up to handle the demanded bio-conversion efficiently,
any microbial strain also has to perform under industrial process conditions in order
to be an apt production strain. Large-scale production conditions are inherently more
challenging for microorganisms as they comprise e.g. higher levels of compound
inhomogeneity [30, 95] and huge variations in the local hydrostatic pressure.
Parameters influence growth and production capabilities of the used microorgan-
isms and include, amongst others, pH value [187], initial substrate concentration
[168] and temperature [14, 149, 151]. The set-point of controllable parameters
in an industrial context should generally be profit-driven and focus on productivity
(producing fast) and yield (producing efficiently). Other economic factors of bio-
chemical engineering might also play a role, e.g. reduced amount of cooling water
required.
4
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N
O OH
NH
Substrate Fermentation Product
Ectoine
Lysine
Glucose
Xylose
Fig. 4: Microbial conversion of raw materials into value added chemicals. The depicted
molecules reflect the substrates and products used in this work. One of each (glucose and
lysine) is natural to C. glutamicum while the others are not naturally utilized/synthesized.
1.2 Main objectives
The aim of this work was to extend the biotechnological performance of C. glutami-
cum by addressing the three segments of the conversion of raw materials into value
added chemicals (Fig. 4):
• Production of L-lysine from D-xylose. Implementation of a bioreactor fed-batch
process emulating industrial production conditions.
• Characterization the correlation between lysine production and cultivation
temperature for different strains of C. glutamicum. Unraveling of the underlying
metabolic responses to changes in cultivation temperature.
• Broadening of the product portfolio of C. glutamicum towards the compatible
solute ectoine, a promising substance for a diverse set of possible and existing
applications in the cosmetic and pharmaceutical industry.
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THEORETICAL BACKGROUND
2.1 C. glutamicum as industrial workhorse
2.1.1 Core metabolism
The soil bacterium C. glutamicum is one of the most important microorganisms
for amino acid production today [188]. The two amino acids with the largest
worldwide production volume by far, L-glutamate and L-lysine, are mainly produced
by this microorganism [16]. Contemporary lysine production uses mixtures of sugars
(glucose, fructose, sucrose) from sugar cane, starchy biomass or molasses as substrate
[102, 238].
The uptake of these sugars is mediated by three phosphoenolpyruvate dependent
phosphotransferase systems (PTS, see Fig. 5). A fourth PTS with unknown function
is reported in C. glutamicum [141]. Additionally, glucose is taken up via non-PTS
routes [79, 114, 128]. At least one of these is uninhibited by high osmolarity, which
can occur during fed-batch fermentations [60]. It was shown that overexpression
of non-PTS glucose uptake in a PTS deficient strain can be beneficial for lysine
production [79, 128]. Unlike other bacteria, the PTS uptake in C. glutamicum is only
marginally affected by catabolite repression [242]. In fact, the uptake systems are
rather expressed constitutively, which enables simultaneous consumption of mixtures
of sugars [45]. This is a clear advantage for industrial fermentation, where media
often contain a variety of such carbon sources.
The central carbon metabolism of C. glutamicum comprises the Embden-Meyer-
hof-Parnas (EMP) pathway, the pentose phosphate (PP) pathway, the tricarboxylic
acid (TCA) cycle and a range of anaplerotic reactions around the pyruvate node (Fig.
6
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Fru Glc
PTSFru
(ptsF)
PTSSuc
(ptsS)
PTSGlc
(ptsG)
Glc
IolT1
(iolT1)
IolT2
(iolT2)
EIIBgl
GLK PPGK GGL2647
Glc Glc
GlcG6P
ATP/PolyPnADP/PolyPn-1
Suc
Suc6PF1P
FBP
PEP
Pyr
PEP
Pyr
PEP
Pyr
Fig. 5: Sugar uptake in C. glutamicum ATCC 13032. PTS = phosphotransferase systems, Fru
= fructose, Suc = sucrose, Glc = glucose, PEP = phosphoenolpyruvate, Pyr = pyruvate, G6P
= glucose 6-phosphate, Suc6P = sucrose 6-phosphate, F1P = fructose 1-phosphate, FBP =
fructose 1,6-bisphosphate, ATP = adenosine triphosphate, ADP = adenosine diphosphate,
PolyPn = polyphosphate, IolT = myo-inositole transporter, EII = enzyme II permease. GLK,
PPGK and GGL2647 are glucokinases. Gene names are shown in brackets. The molecules
representing the entry point into the central carbon metabolism are depicted with a dashed
frame. Figure adapted from [242] and [79].
6). The EMP pathway catalyzes the conversion of phosphorylated sugars into phos-
phoenolpyruvate and pyruvate, two molecules that represent important metabolic
intermediates and precursers for many metabolites [148]. Adenosine triphosphate
(ATP) is generated along the way. The PP pathway comprises an oxidative part,
generating NADPH, and a non-oxidative part, consisting of reversible interconver-
sion reactions with erythrose 4-phosphate, ribose 5-phosphate and sedoheptulose
7-phosphate as pathway intermediates. Erythrose 4-phosphate is a precursor for aro-
matic amino acids [242] and ribose 5-phosphate is a building block for nucleotides
[148]. Additionally, the PP pathway is a key route for lysine synthesis [136, 231,
234]. The quantification of metabolic fluxes through 13C labeling studies revealed
that this pathway supplies major amounts of NADPH during growth of C. glutamicum
on typical industrial sugars such as glucose [136], sucrose [235] and xylose [36].
Fructose on the other hand is a suboptimal carbon source for lysine bio-synthesis
[100]. The different entry point of fructose into the central carbon metabolism,
omitting the PP pathway (Fig. 5 and 6) leads to reduced NADPH supply and lysine
production [100]. Due to the high NADPH demand during lysine production, the PP
pathway has been a focus of strain optimization efforts [10, 13, 149].
The TCA cyle is the core pathway of energy metabolism in many aerobic microor-
ganisms, including C. glutamicum. Its major function is the generation of reducing
7
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Glucoseex
Pyr
PEP
Glucose 6-P
NADP+
NADPH
Fructose 6-P
6-P Gluconolactone
Fructose 1,6-BP
1,3-BP Glycerate 3-P Glycerate
Glyceraldehyde 3-PDihydroxy-acetone-P
ADP
ATP
2-P Glycerate
NAD+
NADH ADP ATP
Phosphoenolpyruvate
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ATP
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Erythrose 4-P
Sedoheptulose 5-P
NADP+
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NADH
ATP
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QH2
H+
H2O
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Fig. 6: Central carbon metabolism of C. glutamicum. PEP = phosphoenolpyruvate, Pyr =
pyruvate, ATP = adenosine triphosphate, ADP = adenosine diphosphate, GTP = guanosine
triphosphate, GDP = guanosine diphosphate, FADH = flavin adenine dinucleotide (re-
duced ), NAD(P)H = nicotinamide adenine dinucleotide (phosphate) (reduced ), NAD(P)+ =
nicotinamide adenine dinucleotide (phosphate) (oxidized), Pi = phosphate, CoA(-SH) =
coenzyme A (unbound), Q(H2) = coenzyme Q (reduced).
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equivalents (NADH, NADPH, FADH) and biochemical energy as ATP. Additionally,
the TCA cycle supplies anabolism with precursor molecules. In order to replenish the
TCA cycle, C. glutamicum possesses reactions that supply TCA cycle intermediates –
the so called anaplerotic reactions. For lysine production, the anaplerotic reactions
involved in the formation of oxaloacetate/malate (OAA/Mal) from phosphoenolpyr-
uvate/pyruvate (PEP/Pyr) are of immense importance as both oxaloacetate and
pyruvate are product precursors. C. glutamicum has a remarkable array of enzymes at
this metabolic node: PEP carboxylase (PEP→OAA) [49], Pyr carboxylase (Pyr→OAA)
[162], PEP carboxykinase (OAA→PEP) [89], OAA decarboxylase (OAA→Pyr) [88]
and malic enzyme (Mal→Pyr) [211, 242].
2.1.2 Lysine biosynthetic pathway
The lysine synthesis (Fig. 7 A) starts from the TCA cycle intermediate oxaloacetate as
well as from pyruvate. It branches off into two parallel routes at the level of L-∆1-tetra-
hydropicolinate, both of which converge at meso-diaminopimelate. One of the two
routes, the multi-step succinylase pathway, is active even when only little ammonium
is available [48, 182] (Fig. 7 B). In contrast, the one-step ammonia-dependent
dehydrogenase pathway, is mainly active at a high concentration of ammonium [194]
(Fig. 7 B). In total, the generation of one molecule of lysine requires one molecule of
each, pyruvate and oxaloacetate, two molecules of ammonium and the oxidation of
four molecules of NADPH to NADP+.
Lysine biosynthesis in C. glutamicum is mainly controlled by the enzyme aspar-
tokinase, which is feedback inhibited by lysine and threonine. The release of this
inhibition is a key to lysine producing strains [98]. Multiple point mutations have
been reported in the literature that remove the feedback inhibition by the two amino
acids [38, 150, 192, 244].
Since C. glutamicum natively does not possess pathways for lysine degeneration,
lysine would accumulate inside the cell, if produced in large quantity. Therefore ,
C. glutamicum excretes lysine via a permease, encoded by lysE [217]. The low affinity
of this permease towards its substrate ensures activity only in case of intracellular
lysine accumulation [218].
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Fig. 7: Lysine biosynthetic pathways in C. glutamicum. The precurser molecules are oxalo-
acetate and pyruvate (inside dashed frames). A: ATP = adenosine triphosphate, ADP =
adenosine diphosphate, NADPH = nicotinamide adenine dinucleotide phosphate (reduced),
NADP+ = nicotinamide adenine dinucleotide phosphate (oxidized ), CoA(-SH) = coenzyme A
(unbound), Glu = glutamate, 2OG = α-Ketoglutarate. Gene names (red italics) are listed
on page vi. B: Carbon flux through the two parallel biosynthetic routes towards lysine at
different levels of ammonium concentration [48, 182, 194].
2.1.3 Product portfolio
Production of amino acids. C. glutamicum is the dominant and classical producer
of amino acids, originally discovered in a screening program for glutamate producing
organisms [108]. Soon after that, L-lysine was also established as a product, secreted
by a C. glutamicum mutant [107]. Today, these two amino acids are still the main
products (by volume) of C. glutamicum by far [16], but over time C. glutamicum
has developed into an industrial workhorse with a large range of products. It is
not surprising that C. glutamicum has been used to produce other amino acids as
L-methionine [25], L-arginine [77], L-tryptophan [74], L-alanine [90] and L-serine
[161], reaching impressive titers of over 50 g L-1 for some of these products [16].
Researchers also made use of the stereospecificity of biological reactions and used
10
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C. glutamicum to produce D-amino acids [196].
Other products. Apart from amino acid production, C. glutamicum has been used
for the generation of biofuels like ethanol [82] or isobutanol [23]. Ethanol is not
only a biofuel, but also member of a revised list of promising chemicals that can
serve as building blocks in a biorefinery based economy [28]. Glutamic acid, the
major product of C. glutamicum, had been included in the initial list [227] and
organic acids like succinate and lactate are included in both publications. The two
organic acids are natural products of C. glutamicum during anaerobic cultivation
[83]. Using metabolic engineering, titers of 146 g L-1 (succinic acid [156]) and 120
g L-1 (lactic acid [155]) could be reached. Other chemicals successfully produced in
C. glutamicum are diamines like putrescine [139] and cadaverine [34], two important
chemicals necessary for the production of bio-based polyamides.
Economical and ecological considerations. As researchers, politicians and the
general public become increasingly aware of the scarcity of fossil resources in the
recent decades, alternative production routes for fuels and commodity chemicals
are sought after, basically as a way to short-cut the global carbon cycle [134]. A
biotechnological approach to contribute to the solution of this pressing challenge is
the concept of biorefineries, converting biomass (often waste biomass) into valuable
products [35, 122]. Likewise, more traditional bioproduction, which relies on e.g.
sugars as substrate, generates value added chemicals, i.e. chemicals of higher
economical value than the educt, from renewable sources. It has many advantages
over petrochemical processes, like stereospecificity, low process temperatures and
independence of fossil raw materials, hence no risk of depletion of the substrate.
The added monetary value varies widely for the different products. Bulk chemicals
with high production volumes are usually less expensive due to the ‘volume effect’
or ‘economy of scale’ and because the high demand triggers competition. Fig. 8
illustrates this for the amino acid market, where the substances with the highest
annual production (lysine and glutamate) have the lowest market value per unit
while lower annual production amounts correspond to higher prices, as is the case
for histidine and serine.
The market value of any given substance is a decisive factor when considering
the production. In order to maximize profit, the three key performance indicators –
11
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Fig. 8: Worldwide annual production and costs of amino acids [46]. All amino acids shown
graph can be produced by C. glutamicum, although so far not all with economically feasible
titers [15, 73, 214]. Arg = arginine, Asp = aspartic acid, Cys = cysteine, Glu = glutamic
acid, Gly = glycine, His = Histidine, Ile = isoleucine, Leu = leucine, Lys = lysine, Phe =
phenylalanine, Ser = serine, Thr = threonine, Val = valine.
titer, yield and productivity – have to be considered. For any production process it is
desirable to attain high product titers in order to decrease the cost of downstream
processing. Yet for ‘high value’ products, this factor might be of lesser importance, as
even with increased formulation cost still a profit can be made due to high market
price. This applies also to the yield. With valuable products, the relative low influence
of inefficient (i.e. low-yield) substrate utilization to the overall profit margin leads to
less emphasis on this key performance indicator. The opposite holds true for cheap
bulk chemicals like lysine. Here, high titers and yields are crucial, as the substrate
cost often makes up a significant portion of the overall cost [41, 98].
Compatible solutes and ectoine. Chemical chaperones are a class of substances
that comprises small, polar and highly water-soluble organic osmolytes like trehalose,
glycine betaine, proline and the tetrahydropyrimidines ectoine and 5-hydroxyectoine
[29, 99, 184, 237]. They protect proteins against aggregation, promote their proper
folding under otherwise denaturing conditions, and are fully compliant with cellular
physiology, biochemistry and protein function [71, 199, 200, 241]. Due to these
attractive properties, industry advertises ectoines as protective compounds for health
12
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Fig. 9: Metabolic pathway for ectoine and 5-hydroxyectoine production from the building
block L-aspartate-β-semialdehyde, synthesized from the TCA cycle intermediate oxaloacetate
by the enzymes aspartokinase (Ask; EC: 2.7.2.4) and aspartate-semialdehyde-dehydrogenase
(Asd; EC: 1.2.1.11) (see Fig. 7) and then converted into ectoine and 5-hydroxyectoine by
L-2,4-diaminobutyrate transaminase (EctB; EC: 2.6.1.76) to form L-2,4-diaminobutyrate,
a metabolite that is then acetylated by 2,4-diaminobutyrate acetyltransferase (EctA; EC:
2.3.1.178) to produce N-γ-acetyl-2,4-diaminobytuyrate, which is subsequently transformed
to ectoine via a water elimination reaction by ectoine synthase (EctC; EC: 4.2.1.108). Ectoine
can then serve as substrate for the formation of 5-hydroxyectoine through the activity of
ectoine hydroxylase (EctD; EC: 1.14.11.). Gene names (red italics) are listed on page vi.
care products and cosmetics [61, 124, 160]. Ectoines possess excellent stabilizing
effects on biological molecules; e.g. proteins, cell membranes, DNA, and even entire
cells. To some extent they also find application as in vivo folding catalyst for the
recombinant production of proteins [8] and as enhancers for polymerase chain
reactions [181]. The anti-inflammatory effect of ectoine even suggests a medical
oriented application in the future for treating lung inflammation [204] and colitis [1],
and for tissue protection in ischemia [223]. These properties coupled with the current
industrial bio-process for ectoine production being elaborate and detrimental to the
equipment [33, 120] render the heterologous production of ectoines in C. glutamicum
an interesting aim.
Although chemical synthesis of ectoines is certainly possible [181], their large-scale
production with a high degree of purity and stereo-specificity is complicated and
costly. Chemical synthesis was consequently out-competed by a biotechnological
production route using the halophilic bacterium Halomonas elongata [175]. A major
problem with this production is the requirement of high-salinity growth medium,
which leads to slow production, corrosion of the equipment and an overall difficult
to handle process [147].
In vivo, ectoine is synthesized from the precursor L-aspartate-β -semialdehyde
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(ASA), a central hub in microbial amino acid production [131], by three successive
enzymatic steps that are catalyzed by the L-2,4-diaminobutyrate transaminase (EctB),
the 2,4-diaminobutyrate acetyltransferase (EctA) and the ectoine synthase (EctC)
[132, 157] (Fig. 9). A substantial subgroup of the ectoine producers can convert
ectoine into 5-hydroxyectoine through the activity of the ectoine hydroxylase (EctD)
[33, 170] (Fig. 9). The ectoine biosynthetic genes are normally organized in an
operon (ectABC) [118, 119, 132, 169] that might also comprise the ectD gene [33, 57,
165]. Expression of the genes involved in the ectoine synthesis is typically induced
in response to increased osmolarity [37, 118, 119, 184] or extremes in growth
temperature [37, 119]. Transcriptional profiling indicated that the cellular levels of
ASA could be a potential bottleneck in the synthesis of ectoines [21].
All in all, through the combination of its natural set-up as a robust and versatile
soil microorganism and of metabolic optimization and systems metabolic engineering
(see chapters 2.1.4 – 2.1.6), C. glutamicum is capable to produce a variety of value-
added chemicals.
2.1.4 Strain development and metabolic engineering
The improvement of C. glutamicum for industrial fermentation is a major goal since
many decades. Due to a lack of insight into microbial biochemistry and genetics,
at first, initial production strains of C. glutamicum could only be generated via
selection, often coupled to active random mutagenesis. For example, glutamic acid
producing strains were obtained by exposure of cell suspensions to UV radiation and
selection involving coverage of mutated colonies with glutamate auxotrophic bacteria
[127]. A second efficient approach for selection of desirable traits was the use of
antimetabolites or analogs. A prominent example is the use of S-(2-aminoethyl)
cysteine, an analog of lysine, and L-threonine, which led to the discovery of strains
with a mutated aspartokinase, uncoupled from feed-back regulation [98]. These
approaches led to the development of powerful production strains able to accumulate
100 g L-1 of L-lysine with yields of up to 50 % [72, 126]. On the other hand, random
mutagenesis inherently caused the integration of hundreds of unspecific mutations
into the genome. These can lead to detrimental changes and unwanted traits like
weak stress response, poor growth capability or extensive nutritional requirement
[9].
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With a deeper understanding of microbial genetics, a rapidly increasing set of tools
for their manipulation and the sequencing of the complete genome of C. glutamicum
[72, 93, 207], genetic, i.e. metabolic engineering became feasible to rationally
generate strains with improved production characteristics. One important tool
for example was the levansucrase based system for selection of mutants, which
allows simple identification of positive clones during integrative modification of
C. glutamicum genes [84, 176].
A metabolic engineering project where this tool was successfully applied, was the
production of ethanol in C. glutamicum [82]. Disruption of the native genes ldhA
and ppc and the heterologous expression of the Zymomonas mobilis genes adhB and
pdc led to an substantial increase in the ethanol produced. Metabolic engineering
was also applied to C. glutamicum to broaden the substrate spectrum. Episomal
expression of the E. coli xylA gene coding for xylose isomerase enabled xylose
utilization [97]. The likewise employment of the genes glpF, glpK and glpD, also from
E. coli, led to growth and lysine production from pure and crude glycerol [138, 171].
Another successful approach of metabolic engineering was the replacement of the
native D-lactate dehydrogenase promoter of C. glutamicum by the strong promoter
of the superoxide dismutase of the same organism [146]. This modification led
to an improved utilization of lactate as a substrate and ultimately enhanced lysine
production from that substrate.
Despite these successful examples, the inherent limitation, faced by metabolic
engineering approaches, boils down to a lack of system wide knowledge. This is also
the reason, why many bacterial modifications that can be identified as pure metabolic
engineering, aim at more or less obvious targets like the usage of heterologous genes
to enable novel substrates or products. Due to the complexity of the biochemical
pathways and their regulation, metabolic engineering at a more intricate level
requires a better understanding of the system to be modified, as presented in chapters
2.1.5 and 2.1.6.
2.1.5 Systems Biology
The systems-wide, holistic approach toward understanding complex biological sys-
tems is referred to as systems biology. In this discipline, various omics-techniques as
well as in silico modeling play a crucial role [159].
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Genomics provides the genome sequence of an organism, which sets the frame
for the capabilities of the bacterium [153]. The C. glutamicum ATCC 13032 genome
has been sequenced by various research groups [72, 93]. It is over 3 Mbp in size
and contains roughly 3000 genes. Genome scale stoichiometric models allowed the
response simulation the C. glutamicum metabolism to environmental changes [109]
and prediction of target for improved production of organic acids [189].
Transcriptomics reveals the set of genes, translated into mRNA, which can give
context to the function of genes whose purpose could not be predicted by gen-
omics [192]. Using techniques such as RT-PCR (reverse transcription polymerase
chain reaction), a limited set of genes can be quantified with high precision [54].
DNA Microassays and whole transcriptome shotgun sequencing (RNA-seq) enable
transcriptional analysis on a genomic scale [245]. The massive amount of data
generated in such experimental set ups requires advanced computational power
and techniques, for example normalization of the data for noise error reduction or
clustering according to the co-expression of the genes [245].
Proteomics provides accurate information on the intracellular protein amount.
Techniques like 2D-PAGE allow for the separation and quantification of many proteins
in a complex matrix and e.g. MALDI-TOF MS (Matrix-assisted laser desorption/ionization–
time of flight–mass spectrometry) and LC-ESI-MS/MS (liquid chromatography–
electrospray ionization–mass spectrometry) analysis can be used to identify proteins
[177].
Metabolomics quantifies intracellular metabolite levels and is useful to identify
enzymatic bottlenecks via metabolite accumulation [66]. The method is technically
challenging due to high turnover rates and huge chemical diversity of the analytes
[26, 111].
Fluxomics is the most ‘phenotypical’ of all omics techniques. It most closely
resembles the actual effect of certain conditions on the microbial central metabol-
ism and relevant biosynthetic routes by providing information about the carbon
fluxes through the various biochemical routes in an organism. This can be done by
employing stoichiometric models in combination with data of biomass generated
with isotopic tracers like 13C-labeled sugars [112, 229]. With this technique it was
possible to show the metabolic differences during growth and lysine production of
C. glutamicum on glucose and fructose, like e.g. the drastically reduced carbon flux
through the pentose phosphate pathway on the latter substrate [100]. Similarly, iso-
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topic tracer studies have been used to unravel preferred use of the Entner-Doudoroff
pathway in marine microorganisms [110], characterize the differences in the carbon
metabolism between a wild type and a riboflavin producing strain of Ashbya gossypii
[87] or even to investigate uropathogenic microbes [20]. These examples show the
diversity and power of the tool of isotopic labeling.
For a true system-wide understanding, ideally information from different omics
techniques is combined. The integration of fluxome, transcriptome and metabolome
data of C. glutamicum ATCC 13287 e.g. revealed a strong correlation between the
glucose uptake flux and the expression of glucose phosphotransferase genes, while
the lysine biosynthetic genes were constantly expressed despite substantial changes
in carbon flux [117].
2.1.6 Systems metabolic engineering
As the name suggests, systems metabolic engineering combines knowledge and
holistic viewpoints from systems biology with tools from metabolic engineering for
a ‘design-based creation of tailor-made overproducers that are optimized at the global
level’ [236].
A successful example for systems metabolic engineering is genome breeding [150].
Of the lysine over-producer C. glutamicum B-6 derived by classical mutagenesis, 16
relevant genes were compared to the ancestor strain ATCC 13032. Three mutations
(V59A hom, T311I lysC and P458S pyc) were then implemented in the genome of
C. glutamicum ATCC 13032, which led to an over-producing strain with excellent
properties and only minor and specific changes in the genetic background compared
to the wild type.
A lysine hyper producing strain with even better production properties was gener-
ated by integration of 12 rational modifications into the C. glutamicum genome [18].
In addition to the three amino acid exchanged named above, other modifications
were aimed at the attenuation of the TCA cycle (ATG→GTG start codon in icd [11]),
the increase of carbon flux through the PP pathway (strong promoters Ptuf and Psod
in front of fbp and tkt, respectively [13]), the anaplerotic node (∆pck, Psodpyc) and
an increased carbon flux towards lysine (2×ddh and lysA, PsoddapB, PsodlysCG1A). All
these modification made use of the technique for stable integration of changes into
the genome mentioned in chapter 2.1.4 [84]. This truly system wide approach led to
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a strain capable of producing up to 120 g L-1 lysine with a yield of 55 %.
In an excellent example for the integration of multiple omics techniques for the
generation of advanced production-strains, systems metabolic engineering was used
to generate and improve a basic C. glutamicum strain for cadaverine production.
Conversion of lysine to cadaverine was enabled by integration of the E. coli ldcC
gene coding for the lysine decarboxylase into the C. glutamicum genome [103].
Hereby, the gene was codon-optimized for the expression in C. glutamicum and
put under the control of the strong Ptuf -promoter and many modifications that had
proven beneficial for lysine production (see above) were also implemented in this
C. glutamicum DAP-3c strain. By-product formation by acetylation of the product
was then eliminated by the use of deletion mutants which made more efficient
production possible [104]. C. glutamicum DAP-3c was further improved by genome-
wide transcriptome analysis which unraveled a gene responsible for the export of
cadaverine which also could subsequently be augmented by putting it under the
control of the Ptuf -promoter [105]. Finally, fluxome analysis allowed a detailed
evaluation of the differences in the carbon flux between the strains [106]. Taken
together, the consequent employment of systems metabolic engineering enabled the
creation of a superior production strain able to secrete 90 g L-1 cadaverine [106]
2.2 Alternative renewable feedstocks for bio-based
production
C. glutamicum is able to utilize a wide variety of molecules as a substrate [125]. In
addition to glucose, fructose, sucrose, ribose and mannose, also organic acids like
acetate, succinate and lactate are used as a substrate [35]. The relatively low level
of catabolite repression [242] and the ability to co-utilize multiple carbon sources
are highly desirable for industrial fermentation [45].
Traditionally, large-scale fermentation with Corynebacteria use substrates like
starch hydrolysate (North America) or sugar cane or beet molasses (Asia, Europe)
[102, 238]. Hence it comes as no surprise that strain engineering in the past
intensely focused on glucose [78, 113], fructose [100] and sucrose [235], the major
constituents of these raw materials. Direct utilization of starch by C. glutamicum was
achieved via heterologous expression and secretion of an amylase from Streptomyces
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griseus [185] and via surface display of a Streptococcus bovis α-amylase [205, 206].
As high-starch materials like corn, potatoes or cassava are available worldwide,
further efforts are important to enable more integrated biorefinery processes for
C. glutamicum. Due to its high availability as a major feedstock in agriculture, silage is
another substrate of interest [146]. Two major carbon sources of silage juice, lactate
and glucose, can be readily utilized by C. glutamicum [145]. Lysine production on
silage juice was successful with decent yields, but the final lysine titers of about 3
g L-1 are far too low to be of industrial interest [145].
Coupled to increasing demands for bio-based chemicals, the use of traditional
feedstocks, mentioned above, creates conflicts as they are also suitable for human nu-
trition or at least compete for arable land with food plants [179]. Hence, alternative,
widely available, cheap, renewable feedstocks, not competing with human nutrition,
are ethically, ecologically and economically desirable [34].
Whey is a waste product of the diary industry and hence abundantly at hand [7].
Yet, even though C. glutamicum has been genetically modified to utilize its main
constituents lactose and galactose [9, 35], the production of L-lysine from this raw
material is not beyond the proof of concept stage. A bit more advanced, the use
of the non natural substrate glycerol has been established in C. glutamicum [171]
and production of amino acids and putrescine was successfully implemented [139].
Glycerol used to be an attractive product itself at some point, but now is a promising
substrate as large quantities are produced as waste during biodiesel production
[247].
One extremely promising feedstock candidate, fulfilling the desirable criteria men-
tioned above is lignocellulose, a major component of plants. It can be derived from a
multitude of different sources like forestry or agricultural (crop straw), industrial
(pulp and paper industry) or municipal waste products [3, 6, 202]. Lignocellulose
consists of cellulose (40-50 %), lignin (10-25 %) and hemicellulose (20-30 %) [40].
Cellulose, the most abundant polymer on earth [130], is a polymer built from β-
1,4-linked glucose units [5]. The easily digestible monomer is an advantage for
the application in fermentation, but cellulose has to be treated intensely to break it
down into smaller units [40]. Metabolic engineering of C. glutamicum allowed direct
utilization of cellulose for glutamate production [35]. Cellulose, however, has an
important technical use for production of paper and board. The waste streams from
the pulp and paper industry consequently consist of mainly lignin and hemicellulose.
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Table 1: Different types of hemicelluloses. Like many plant derived polysaccharides, hemi-
celluloses exhibit a high molecular diversity [201].
Name Properties
Xylan 4-O-methyl-D-glucuronosyl & α-arabinofuranosyl residues on
a β-1,4 xylopyranose backbone
Glucuronoxylan 2,3- or 2,3-linked glucuronate residues on a β-1,4 xy-
lopyranose backbone
Arabinoxylan 2,3- or 2,3-linked arabinose on a β-1,4 xylopyranose back-
bone
Glucomannan β-1,6 linked residues on a β-1,4 mannose and glucose back-
bone
Xyloglucan β-1,6 xylose residues on a β-1,4 glucose backbone
Lignin is a diverse group of aromatic polymers of phenylpropane units [193] and a
class of molecules not well suitable for microbial conversion [35]. For the pulp and
paper industry as well as for the biofuel production, lignocellulosic raw material with
low lignin content are desirable, but for burning, lignin-rich woods are preferable
due to their high energy density [44].
Hemicellulose is a group of heteropolysaccharides (see Tab. 1) comprising different
sugars like glucose, xylose, mannose, galactose, rhamnose, and arabinose with xylose
usually being the most abundant one [36]. The sugar monomers are recovered from
hemicellulose by acidic hydrolysis with relatively little effort and even at higher yield
than glucose is obtained from cellulose [86]. As a beneficial trait, C. glutamicum
tolerates growth inhibitors like furfurals, hydroxyl methyl furfurals and organic
acids [173] typically present in hydrolysates of lignocellulose and hemicellulose
[59]. Naturally, C. glutamicum does not use xylose as a substrate, but harbors xylose
importers [174] and also xylB, encoding xylulokinase. This enzyme phosphorylates
D-xylulose to D-xylulose 5-phosphate, the last step of xylose catabolism [24]. The
first step, the conversion of D-xylose to D-xylulose is catalyzed by the enzyme xylose
isomerase, coded for by xylA. Indeed, heterologous expression of xylA from E. coli,
alone or in combination with xylB, enables C. glutamicum to use xylose as carbon
and energy source [97]. This has been exploited to engineer C. glutamicum for the
production of amino acids, putrescine [138], cadaverine [36] and succinic acid [220]
from xylose-based raw materials.
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2.3 Bioprocess technology of industrial lysine
production
Beyond the biosynthetic properties of microorganisms, used for a desired bioconver-
sion, their robustness to cultivation in large volumes is crucial for industrial efficiency.
The cultivation vessel provides a defined environment and serves as a barrier to
the outside. Modern bioreactors at laboratory scale are equipped with advanced
measurement and control technology, allowing fine-tuned settings of environmental
parameters [52]. Important parameters controlled by the operator include the tem-
perature, the pH value, the supply with oxygen, substrate or anti-foaming agents
and the power input required for mass transfer (homogenization, dispersion) and
heat transfer. Within a certain operational window, the variation of these parameters
controls the microbial behavior and hence the resulting bioprocess. Bioreactors are
operated in different modes, i.e. batch, fed-batch and continuous mode, depending
on the purpose of the cultivation.
In a batch cultivation, all nutrients (with the exception of oxygen and pH correction
and antifoam agents) are present in the reactor at the time of inoculation. A batch
fermentation requires less sophisticated equipment then the other operational modes,
but allows no stringent control over certain cultivation parameters.
In a fed-batch cultivation, nutrients are supplied to the vessel. This feeding phase
follows an initial batch phase. There are different possible feed regimes, e.g. per-
manent, exponentially increasing feed and feed pulses. The biggest advantage of
this operational mode is the higher total amount of substrate, that can be transferred
into the vessel in a controlled manner without causing (e.g. oxygen-) limitation,
substrate inhibition or by-product formation. This also leads to high final product
concentrations in the vessel, which is advantageous for the downstream processing.
During production phase, auxotrophic strains require low levels of certain supple-
ment at all times, which can also be achieved by the fed-batch operation. Early
homoserine-auxotrophic C. glutamicum strains could be utilized for lysine produc-
tion, if homoserine or threonine was present in limiting concentration [143, 144].
Compared to the batch mode, fed-batch processes need to be constructed with a
larger amount of and also more sophisticated peripheral equipment. In addition to
the storage tank and the pump(s) necessary for the feeding, sensors and software
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apt for the task also have to be in place. A special case of a fed-batch fermentation is
the repeated fed-batch (also called semi-continuous mode), in which a fraction of
the culture broth of the previous fermentation remains in the vessel, and is used as
inoculum for the next fed-batch.
The continuous mode is characterized by a steady (and in most cases constant and
balanced) flow in and out of the bioreactor. This leads to steady state conditions,
which can be easily controlled via the feed rate by the operator. The resulting high
productivity is gained at the cost of product concentration, which is not as high as in
fed-batch cultivations [69]. Again, advanced measurement and control technology
is required to ensure proper operation, but the continuous mode allows for smaller
reactor sizes, which reduces investment costs.
Industrial production of L-lysine is usually conducted in up to 700 m3 large stirred-
tank bioreactors, operated in fed-batch, repeated fed-batch or continuous mode [98].
The latter two have the advantage of shorter down-times and higher productivity,
but exhibit an increased risk of contamination or, in some cases, genetic instability
[72]. Air lift reactors exhibit a more energy-efficient oxygen transfer, but their overall
oxygen transfer rate is too low for the high cell density cultivation of modern lysine
producing C. glutamicum strains [98]. The immense production volumes make
multiple, successively larger seed reactors necessary. This is also due to the tendency
of C. glutamicum to show a prolonged lag phase if the initial cell concentration at
inoculation is too low. In this so called seed train the maintenance of monoseptic
conditions is absolutely essential, as a contaminant like e.g. Bacillus sp. would
outgrow C. glutamicum [98].
Raw materials, currently used in large scale lysine production, include sugar cane
sucrose, starch hydrolysates or molasses as carbon sources, depending on the location
of the production site, with corn starch hydrolysis e.g. dominating in North America
[68]. Ammonia in dissolved, gaseous or saline form is used to provide nitrogen.
Alternatively, complex sources like corn steep liquor are also used. The use of well-
defined raw materials is beneficial for process reproducibility and has increased in
the last two decades [98]. On the other hand, raw materials are a major cost factor
in the production of a bulk chemical with a low price like lysine (see Fig. 8) [41,
163].
Among all parameters, temperature is an important, yet relatively easily control-
lable parameter of a bioprocess, as no advanced measurement and control technology
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is required. Its measurement is usually conducted with simple thermocouple or res-
istance thermometers and regulated via cooling jackets and coils. In contrast to
chemical reactions, bioconversions do not produce heat very rapidly. The bigger
problem lies in the fact that biological reactions take place at comparatively low
temperature, only 5 to 20 ◦C above the temperature of the cooling water, which leads
to poor heat removal capacity [213]. The impact of temperature on the process,
however, is substantial. Microorganisms exhibit optimal growth at specific temper-
atures, depending on the species. For different strains of C. glutamicum, optimal
temperatures around 25 to 37 ◦C are reported [2] and cultivation in the past decades
is typically performed at 30 ◦C [98]. Below and above this optimum, specific growth
rate is reduced. Too high temperatures eventually lead to cell death. The optimal
temperature for growth also might not be the best temperature for the bioprocess as
in some cases slower growth is desirable, e.g. to avoid oxygen limitation. In order to
maintain a constant temperature despite the heat generated by the metabolic activity
of the microorganisms and the mechanical power input of the stirrer, bioreactors are
equipped with cooling jackets and coils [58]. With higher volumes this becomes a
more and more demanding task as the specific volume (volume per surface area)
gets smaller. This means that the metabolic heat, generated by the microorganisms
increases cubically with the volume, but the cooling surface of the vessel wall in-
creases only quadratically, often making expensive cooling coils inside of the reactor
necessary, when scaling up a bioprocess [91].
Amino acid bulk production is often located in close proximity to substrate manu-
facturers [47]. In case of sugar cane this means tropical regions [102], where the
temperature difference between process and cooling water might be even lower,
which further increases the problem to cool large scale production. From a biopro-
cess point of view this illustrates the advantages of running fermentations at higher
temperature. Clearly, the limitation for this are microorganisms, which are sensitive
towards the temperature of their environment. Yet, the clear economic benefits
make it worthwhile to investigate the possible improvement of lysine production
bioprocesses by increased temperature.
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MATERIALS AND METHODS
3.1 Bacterial strains and molecular work
Pre-existing strains. All strains of Corynebacterium glutamicum used in this work
were based on the wild type strain C. glutamicum ATCC 13032 and were obtained
from the American Type Culture Collection (Manassas, VA, USA) and from previous
work [2, 18] (Tab. 2, Fig. 10). Strains were kept as cryostocks made by mixing equal
volumes of 60 % glycerol and culture broth with exponentially growing cells and
freezing them in liquid nitrogen before storage at -80 ◦C.
C. glutamicum Lys1 has a T311I amino acid exchange in the lysC gene, which
results in an aspartokinase, resistant to feedback inhibition by lysine and threon-
ine. The rationally designed strain C. glutamicum Lys12 comprises 12 genomic
modifications [18]. E. coli strains DH5α and NM522 (Invitrogen GmbH, Darmstadt,
Germany) were utilized for amplification and methylation of plasmids, respectively.
The plasmid pTc15AcglM [164], which contained an origin of replication for E. coli
and tetracycline resistance as selection marker, served as expression vector for DNA
methyl transferase, which added the C. glutamicum specific methylation pattern to
plasmid DNA, upon co-expression in E. coli NM522.
Generation of C. glutamicum Lys12K. The episomal vector pClik 5a MCS [115],
which contains a multiple cloning site, an origin of replication for E. coli and for
C. glutamicum as well as a kanamycin resistance selection marker was transformed
into E. coli DH5α cells via a heat shock. For that, 50 µL of E. coli DH5α cells, growing
exponentially on LB medium, and 3 µL (1-50 ng) plasmid DNA were incubated on
ice for 30 minutes, shifted to 45 ◦C for 45 seconds and immediately planted back
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Table 2: Bacterial strains and plasmids used in this work. The genealogy of the strains is
shown in Fig. 10.
Name Relevant feature Ref./Source
E. coli DH5α Heat shock competent cells for plasmid transforma-
tion
Invitrogen
E. coli NM522a Heat shock competent cells for plasmid transforma-
tion and C. glutamicum methylation pattern via plas-
mid pTc15AcglM
Invitrogen
C. glutamicum ATCC 13032 Wild type strain [2, 108]
C. glutamicum Lys1 C. glutamicum ATCC 13032 with a feedback resistant
aspartokinase
[13]
C. glutamicum Ect1 C. glutamicum Lys1 heterologously expressing the
synthetic ectABCD gene cluster
[14, 27]
C. glutamicum Ect2 C. glutamicum Ect1 with deletion of the lysE gene [14, 65]
C. glutamicum Lys12 Lysine hyper producer [18]
C. glutamicum Lys12Kb C. glutamicum Lys12 containing the episomal pClik
plasmid
this work
C. glutamicum Xyl1b C. glutamicum Lys12 containing the episomal pClik
xylAB plasmid
this work
pTc15AcglM Contains an E. coli ORI and genes for tetracycline
resistance as well as for a C. glutamicum specific DNA
methyl transferase
[164]
pClik 5a MCS Episomal replicating plasmid containing an MCS, an
E. coli and C. glutamicum ORI and a kanamycin res-
istance gene
[115]
pClik 5a MCS PgroxylAB pClik 5a MCS with E. coli xylA and xylB genes [36]
pClik int sacB Integrative plasmid containing an MCS, an E. coli ORI
and a levansucrase as well as a kanamycin resistance
gene
[84]
pClik int sacB Ptu f ectABCD pClik int sacB for the replacement of C. glutami-
cum ddh with an codon optimized ectoine synthesis
cluster under the control of the C. glutamicum tuf
promoter
[14]
pClik int sacB ∆lysE pClik int sacB for the disruption of the C. glutamicum
lysE gene
[105]
aTetracycline resistant
bKanamycine resistant
on ice for 2 minutes. Subsequently, 900 µL SOC medium was added, cells were
incubated at 37 ◦C for one hour and were then plated on LB-agar plates with an
appropriate antibiotic. To harvest amplified plasmids, the Gene Jet Plasmid Miniprep
K 0503 or the Gene Jet Plasmid Midiprep K0481 (both Thermo Scientific, Schwerte,
Germany) were used. To achieve the methylation of the DNA apt for utilization by
C. glutamicum, the plasmid amplification step was repeated, using E. coli NM522.
25
Chapter 3 Materials and Methods
Wild type
ATCC13032
Lys1
Ect1
Ect2
∆lysE
ectABCD∆ddh
Lys12
Xyl1
KanR
pClik xylAB
Lys12K
KanR
pClik
...
lysCC932T
Fig. 10: Genealogical tree of the C. glutamicum strains used in this work. C. glutamicum
ATCC 13032 was obtained from the American Type Culture Collection (Manassas, VA, USA)
Lys1 [2] and Lys12 [18] are described in the literature. The generation of C. glutamicum Ect1
and Ect2 was described previously [14, 27, 65]. A red background color represents ectoine
production, a yellow one xylose utilization and strains resistant to kanamycin are labeled
KanR.
Plasmids, isolated from E. coli NM522, were used to transform C. glutamicum
Lys12 cells using electroporation. C. glutamicum cells were grown in BHI medium up
to an optical density of 1.5, harvested via centrifugation (13000×g, 5 min), washed 4
times with and resuspended in ice cold 10 % glycerol to a concentration of 0.125-0.25
gcww mL-1. In chilled electroporation cuvettes (2 mm gap, Bio-Rad, Hercules, CA,
USA), 100 µL of the resuspended cells and 200-500 ng plasmid DNA were mixed.
Electroporation was performed at 2.5 kV, 25 F and 400 Ω with the Gene-Pulser
electroporator (Bio-Rad, Hercules, CA, USA). After the electric pulse, 1 mL of BHIS
medium was added and the cells were then incubated for 1.5 hours at 30 ◦C, then
were spread on BHIS agar plates, containing kanamycin as a selection marker, and
finally were incubated at 30 ◦C for two days. Cells selected for on these plates were
the desired clones and were named C. glutamicum Lys12K.
Generation of C. glutamicum Xyl1. The episomal vector pClik 5a MCS PgroxylAB
was used for expression of the xylose operon [36]. The plasmid contained genes for
xylose isomerase (xylA, ECK3554) and xylulokinase (xylB, ECK3553) from E. coli
K-12 MG1655 under control of the strong constitutive C. glutamicum promoter Pgro,
a multiple cloning site, an origin of replication for E. coli and for C. glutamicum as
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Table 3: Primers used in this work.
Sequence (5’-3’) Function
CACCCTCAACAGTTGAGTGCTGGCAC Verifying integration of the xylAB gene in
pClik 5a MCSATTGTCTGTTGTGCCCAGTCATAG
AGAGTACCTGGGACGCAGCGTCG Verifying integration of the Ptu f ectABCD
gene cluster & disruption of the ddh geneCGTCGCGTGCGATCAGATCGGT
CTCGTTGAACACGGGAGGAA
Verifying disruption of the lysE gene
CACGGACAAATATCTCGATG
well as a kanamycin resistance selection marker. The process of transformation of
C. glutamicum Lys12 was analogous to the one described for C. glutamicum Lys12K
above. For the verification of of the successful transformation, clones from the LBKan
agar plates were transferred to agar plates with a minimal medium containing xylose
as the sole carbon. One of the colonies able to grow in presence of kanamycin and
on xylose was chosen and named C. glutamicum Xyl1.
For strain validation, polymerase chain reaction was performed in addition to
physiological confirmation, like antibiotic resistance and growth on xylose. PCR was
done using a mastercycler EP gradient PCR machine (Eppendorf, Hamburg, Germany)
and either the PWO master, the PCR master (both Roche, Basel, Switzerland) or the
KAPAHiFi Kit (Peqlab, Erlangen, Germany). Primers were obtained from Invitrogen
(Darmstadt, Germany) and are listed in Tab. 3. The annealing temperature Ta of
primers was calculated according to equation 1, were C, G, A and T stand for the
nucleobases cytosine, guanine, adenine and thymine, respectively.
Ta =

64+(nG+nC−16.4)
nA+nT+nC+nG
−5, if ∑ni > 13
(nA+nT ) ·2+(nG+nC) ·4−5, if ∑ni ≤ 13
(1)
Generation of C. glutamicum Ect1 and Ect2. Heterologous production of ectoine
in C. glutamicum was based on the ectABCD biosynthetic gene cluster from Pseudo-
monas stutzeri A1501 [198]. The codon usage was adjusted to that preferred by
C. glutamicum using the proprietary GeneOptimizer R© software (Geneart, Regens-
burg, Germany). The DNA sequence of the codon-optimized ectABCD variant gene
cluster, along with the original sequence of P. stutzeri A1501, can be seen in the
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ectA ectB ectC ectDPtufddh ddh
SpeI SpeI
3448bp
4577bp
5' homologous re-
combination site
3' homologous re-
combination site
Fig. 11: Construct for the integration of the ectoine synthesis cluster into C. glutamicum.
It contained the codon-optimized ectABCD gene cluster based on that present in P. stutzeri
A1501 under the control of the promoter for the tuf gene from C. glutamicum. For genome-
based integration via a double-recombination, the construct was additionally equipped
with flanking regions of about 560 bp DNA sequences, derived from the upstream and
downstream regions of the ddh gene. Recognition sites for the restriction enzyme SpeI were
added to facilitate cloning of this DNA fragment into the vector pClik int sacB [13]. The ddh
gene, encoding diaminopimelate dehydrogenase, was chosen as integration site to minimize
competing carbon flux towards lysine.
appendix (Fig. 36). The complete 4577 bp-sized construct (Fig. 11) was provided by
Geneart (Regensburg, Germany) and included a nucleotide sequence consisting of a
200-bp DNA segment that carried the strong and constitutively active promoter for
the expression of the structural tuf gene (NCgl0480) of the elongation factor Tu of
C. glutamicum and the aforementioned optimized ectABCD gene cluster. Addition-
ally, the construct was flanked by 560 bp-sized homologous recombination sites for
genome-based integration of the construct into the structural ddh gene (NCgl2528),
encoding diaminopimelate dehydrogenase. Artificial SpeI digestion sites were added
at the 5’ and 3’ end.
Ligation of this construct into the pClik int sacB plasmid was conducted with the
Rapid Dephos & Ligation Kit (Roche, Basel, Switzerland). The resulting plasmid
pClik int sacB Ptu f ectABCD was used for the integration of the synthetic gene cluster
into C. glutamicum Lys1. It contained the ectoine-production construct (Fig. 11), an
origin of replication for E. coli as well as a kanamycin resistance and a sacB gene as
selection markers.
The further treatment of the plasmid (heat shock into E. coli, electroporation
into C. glutamicum Lys1) was done as described above, but more plasmid DNA
(1-5 µg) was used in the electroporation step. Single C. glutamicum colonies, able
to grow in the presence of kanamycin, were further cultivated without selective
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pressure to allow for the second recombination event and were subsequently plated
on CMSac agar plates [84]. A colony sensitive to kanamycin and insensitive to sucrose,
C. glutamicum Lys1 ∆ddh Ptu f ectABCD, was named C. glutamicum Ect1.
The plasmid pClik int sacB ∆lysE [105] contained homologous recombination sites
for genome-based disruption of the lysE gene (NCgl1214), an origin of replication
for E. coli as well as a kanamycin resistance and a sacB gene as selection markers.
Transformation of this plasmid into C. glutamicum Ect1 was done as described above.
The resulting strain, C. glutamicum Ect1 ∆lysE, was named C. glutamicum Ect2. The
construction of C. glutamicum Ect1 was performed by Nicole Borchert [27] and strain
C. glutamicum Ect2 was constructed by Björn Johannes Harder [65].
For strain validation, polymerase chain reactions were performed in addition to
physiological confirmation, like ectoine production. PCR was done as described
above with primers listed in Tab. 3.
3.2 Chemicals
Complex media ingredients like BHI (brain heart infusion) powder, yeast extract,
peptone and tryptone as well as agar were obtained from Becton & Dickinson
(Franklin Lakes, NJ, USA). Isotopically labeled substrates, i.e. 1-13C and U-13C
glucose were obtained from Euriso-Top (Saarbrücken, Germany). If not specified
otherwise, all other chemicals were obtained from Sigma-Aldrich (St. Lois, MO, USA)
or Merck (Darmstadt, Germany) at analytical grade quality. Water was purified by a
Milli-Q Integral water purification system (Merck, Darmstadt, Germany).
3.3 Media for shake flask cultivations
Complex cultivation media used in this work are listed in Tab. 4. Chemically defined
media are given in Tab. 5. If a solid version of a medium was required, 18 g L-1 agar
were added before sterilization. The sterilization was performed by autoclaving at
121 ◦C and 2 bar for 20 min. If required, kanamycin and tetracycline were used as
antibiotics at concentrations of 50 and 12.5 mg L-1, respectively.
Chemically defined media cdm1 and cdm2 were prepared by mixing sterile stock
solutions (Tab. 5) and adding autoclaved deionized water. Solutions (A)-(G) and (K)
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Table 4: Composition of complex media.
Medium Amount (g) Component Water (mL) Comment
BHI 37 BHI 1000
BHIS 37 BHI 750
250 mL 2 M sorbitol
solution added after
autoclaving
CM
2.5 NaCl
930
50 mL 40 g L-1 urea
solution and 20 mL 500
g L-1 glucose solution
added after autoclaving
5 Yeast extract
10 Peptone
5 Meat extract
CMSac
2.5 NaCl
930
50 mL 40 g L-1 urea
solution and 20 mL 500
g L-1 glucose solution
added after autoclaving
5 Yeast extract
10 Peptone
5 Meat extract
100 Sucrose
LB
5 NaCl
10005 Yeast extract
10 Tryptone
SOC
0.5 NaCl
975
5 mL 2 M MgCl2 solution
and 20 mL 1 M glucose
solution added after
autoclaving
5 Yeast extract
0.186 KCl
20 Tryptone
were sterilized by autoclaving, (H)-(J) by filtration (0.2 µm Minisart filter; Sartorius,
Göttingen, Germany). The medium cdm1 was used for shake flask cultivations with
xylose as the carbon source and the glucose-based reference cultivations thereof. The
cdm2 medium was used for all other shake flask cultivations on chemically defined
medium.
3.4 Media for bioreactor cultivations
Lysine production from xylose. The batch medium for lysine production from xyl-
ose contained (per liter medium): 72.4 g root beet molasses (Paik Kwang Industrial,
Gunsan, South Korea), 35 mL corn steep liquor (BASF, Ludwigshafen, Germany) , 85
g xylose, 250 µL H3PO4 (85 %), 40 g (NH4)2SO4, 250 mg KH2PO4, 100 mg MgSO4.
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Table 5: Composition of chemically defined media.
Stock Concentra- Component Comment mL in 1 L
solution tion (g L-1) cdm1 cdm2
A
40 NaCl
25 252.2 CaCl2
8 MgSO4
B 150 (NH4)2SO4 pH 7.0 100 100
C 100 Glucose 100
D 100 Xylose or glucose 100
E 100
N-(2-Acetamido)-2-
aminoethanesulfonic
acid (ACES)
pH 7.4 100
F KXHXPO4a pH 7.8 100
G 2 FeSO4.7H2O pH 1.0 10 10
H 30
3,4-dihydroxybenzo-
ic acid
in 0.3 M
NaOH solution 1 1
I
0.2 FeCl3.6H2O
pH 1.0 10 10
0.2 MnSO4.H2O
0.05 ZnSO4.H2O
0.02 CuCl2.2H2O
0.02 Na2 B4O7.10H2O
0.01 (NH4)6Mo7O24.4H2O
J
0.025 Biotin
20 200.05 Thiamin
0.05 Ca-pantothenate
K 23 K2HPO4 10
a2 M KH2PO4 and 2 M K2HPO4 mixed to achieve a pH of 7.8
7H2O, 11 mg FeSO4.7H2O, 10 mg citric acid, 9 mg biotin, 15 mg thiamin-HCl, 60
mg Ca-pantothenate and 18 mg nicotinamide. The feed medium, added during the
fed-batch phase, contained 162.5 g molasses, 585 g xylose and 40 g (NH4)2SO4 per
liter.
Ectoine production from glucose. One liter of batch medium contained the fol-
lowing stock solutions: (A) 25 mL salt solution (40 g L-1 NaCl, 2.2 g L-1 CaCl2, 8 g L-1
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MgSO4), (B) 50 mL ammonium solution (400 g L-1 (NH4)2SO4, pH 7.0), (C) 100 mL
sugar solution (500 g L-1 glucose), (D) 100 mL buffer solution (2 M KH2PO4 and
2 M K2HPO4 mixed to achieve a pH of 7.8), (E) 10 mL yeast extract (50 g L-1), (F)
10 mL iron solution (2 g L-1 FeSO4.7H2O pH 1.0), (G) 1 mL complexing agent (30
g L-1 3,4-dihydroxybenzoic acid in 0.3 M NaOH solution), (H) 10 mL trace element
solution (200 mg FeCl3.6H2O, 200 mg MnSO4.H2O, 50 mg ZnSO4.H2O, 20 mg
CuCl2.2H2O, 20 mg Na2 B4O7.10H2O and 10 mg (NH4)6Mo7O24.4H2O per liter,
pH 1.0) and (I) 20 mL vitamin solution (25 mg biotin, 50 mg thiamin and 50 mg
Ca-pantothenate per liter). The feed medium comprised the same stock solutions
in the following composition per liter: (A) 5 mL, (B) 125 mL , (C) 850 mL, (E) 10
mL, (I) 50 mL. Solutions (D), (F), (G) and (H) were omitted. Solutions (A)-(E)
were sterilized by autoclaving, solutions (F)-(I) were sterilized by filtration (0.2 µm
Minisart filter; Sartorius, Göttingen, Germany).
Lysine production from glucose at elevated temperature. One liter of medium
contained the following stock solutions: (A) 25 mL salt solution (40 g L-1 NaCl, 2.2
g L-1 CaCl2, 8 g L-1 MgSO4), (B) 176.5 mL ammonium/sugar solution (248 g L-1
(NH4)2SO4 and 766 g L-1 glucose, pH 7.0), (D) 20 mL buffer solution (2 M KH2PO4
and 2 M K2HPO4 mixed to achieve a pH of 7.8), (E) 10 mL iron solution (2 g L-1
FeSO4.7H2O pH 1.0), (F) 1 mL complexing agent (30 g L-1 3,4-dihydroxybenzoic
acid in 0.3 M NaOH solution), (G) 10 mL trace element solution (200 mg FeCl3.6
H2O, 200 mg MnSO4.H2O, 50 mg ZnSO4.H2O, 20 mg CuCl2.2H2O, 20 mg Na2
B4O7.10H2O and 10 mg (NH4)6Mo7O24.4H2O per liter, pH 1.0) and (H) 20 mL
vitamin solution (25 mg biotin, 50 mg thiamin and 50 mg Ca-pantothenate per liter).
The feed medium comprised the same stock solutions in the following composition
per liter: (A) 5 mL, (B) 969.5 mL, (E) 5 mL, (F) 0.5 mL, (G) 5 mL and (H) 10 mL.
Solutions (A)-(D) were sterilized by autoclaving and (E)-(H) by filtration (0.2 µm
Minisart filter; Sartorius, Göttingen, Germany). The sterility of solution (B) was
ensured by first autoclaving the components in their dry form separately and then
dissolve them in sterile water.
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3.5 Cultivation conditions
3.5.1 Shake flask cultivation
Dispersing a small aliquot of cryostocks on BHI agar and incubation for two days
at 30 ◦C gave rise to enough cell material to be used in suspension cultures. Single
colonies from those agar plates were used as inoculum for a first pre-culture in
complex BHI medium. All shake flask cultures were incubated in baffled shake
flasks filled with 10 % medium at 230 rpm on an orbital shaker with a shaking
diameter of 5 cm (Multitron, Infors AG, Bottmingen, Switzerland). After 12 hours of
incubation, cells were harvested (5 min, 9800×g, 4 ◦C), including a washing step
with sterile NaCl (9 g L-1), and were then used as inoculum for a second pre-culture
in minimal medium. Cells were grown to mid exponential phase, were harvested as
described above, and were then used to inoculate main cultures in minimal medium.
On-line measurement of dissolved oxygen and pH in shake flasks was conducted
with immobilized sensor spots and a flask reader system (SFR, Presens, Regensburg,
Germany), installed in the rotary shaker [180].
3.5.2 Miniaturized cultivations
Small-scale cultivations of C. glutamicum strains were carried out in 1 mL cdm2 in 48-
well flower plates (m2p-labs, Baesweiler, Germany) at 700 rpm using the Biolector
system (DASGIP, Jülich, Germany). The temperature was varied between 27 ◦C
and 42 ◦C. To avoid evaporation of the medium, the plates were sealed with a gas-
permeable membrane (Aera Seal, Sigma Aldrich, Steinheim, Germany). Inoculum
preparation involved shake flask cultivation as described above, and these cells were
then subsequently used to inoculate the multi-well plates to an initial optical density
of 0.3. Cell growth was monitored online via measurement of the optical density
at 620 nm. After 10 h (27 ◦C, 30 ◦C, 35 ◦C) and 20 h (42 ◦C), extracellular and
intracellular accumulation of ectoines was determined. Process monitoring, data
collection, and data processing were carried out with the software suit BioLection
(m2p-labs, Baesweiler, Germany). Miniaturized cultivations were carried out by
Nicole Borchert [27].
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3.5.3 Fed-batch bioprocesses
Bioreactors used were stirred tank reactors with 1 L working volume (SR0700O-
DLS/CWD4 Bioblock, DASGIP AG, Jülich, Germany), equipped with two 6-blade
rushton impellers. The set-up also included temperature, pH (Mettler Toledo, Gießen,
Germany) and dissolved oxygen (DO) probes (VisiFerm, Hamilton, Bonaduz, GR,
Switzerland), aeration (MX4/4 aeration system, DASGIP AG, Jülich, Germany) and
pumps for the addition of base and feeding solution (MP8 pump system, DASGIP
AG, Jülich, Germany). In all cultivations, the initial volume was 300 mL medium.
The pH was controlled at 6.9 ± 0.2 by addition of 25 % NH3 (aq) using the software
DASGIP control (DASGIP AG, Jülich, Germany).
Lysine production from xylose. For preparation of inoculum, cells from glycerol
stocks of C. glutamicum Xyl1 were streaked out on BHI agar and incubated for two
days at 30 ◦C. Cells were then transferred to BHI medium with 10 g L-1 glucose for
rapid biomass generations and incubated for 12 hours at 30 ◦C at 230 rpm on a
rotary shaker with a shaking diameter of 2.5 cm (Certomat IS, Sartorius, Göttingen,
Germany). Afterwards, cells were harvested by centrifugation (10 min, 9800×g,
4 ◦C), resuspended in 20 mL of sterile 9 g L-1 NaCl solution and then were transferred
into the bioreactor with a syringe. During the process, temperature was kept at 30
± 0.3 ◦C. The stirrer speed (400-1200 rpm) and aeration rate (6-12 L h-1) were
adjusted manually to keep the dissolved oxygen concentration above 20 % relative
saturation.
Ectoine production from glucose. Ectoine production of C. glutamicum Ect2 was
also investigated by fed-batch cultivation. Cells pre-grown on agar plates as described
above were transferred in BHI medium with 20 g L-1 glucose and were incubated
for 10 hours at 35 ◦C at 230 rpm on a rotary shaker with a shaking diameter of
2.5 cm (Certomat IS, Sartorius, Göttingen, Germany). Cells were then harvest using
a Heraeus Multifuge 4KR centrifuge (Thermo Fisher Scientific, Rockford, MA, USA,
5350×g, 10 min), re-suspended in 20 mL fermentation medium and then transferred
into the bioreactor with a syringe as an inoculum. Dissolved oxygen was maintained
above 30 % of relative saturation by adjustment of stirrer speed and aeration rate.
These values were initially set to 18 L h-1 and 400 rpm, respectively. The temperature
34
Chapter 3 Materials and Methods
was kept constant at 35 ± 0.3 ◦C. The feeding was automatically controlled via the
dissolved oxygen (DO) level by triggering feed pulses upon pronounced increases in
the DO, which indicated complete sugar utilization by the cells. The fermentation
for ectoine production was done in collaboration with Michael Kohlstedt [111] and
Björn Johannes Harder [65].
Lysine production from glucose at elevated temperature. For production at elev-
ated temperature, cells were grown in a series of pre-cultures (see 3.5.1), then were
harvested, re-suspended in a small volume of fermentation medium and used as
inoculum. Aeration rate (8 to 16 L h-1 air) and stirrer speed (800 to 1200 rpm) were
varied to keep the dissolved oxygen level above 20 % saturation. Temperature was
kept constant at 38 ± 0.3 ◦C or 30 ± 0.3 ◦C as specified below. The feed was added
pulse-wise, coupled to the dissolved oxygen signal as described above.
3.6 Analytical methods
3.6.1 Sample preparation
For the quantification of substrates and of secreted products in the culture super-
natant, the biomass was separated from the culture broth by centrifugation (13000×g,
5 min, 4 ◦C and 10000×g, 15 min, 4 ◦C, centrifuge 5415R Eppendorf, Hamburg,
Germany).
For the quantification of intracellular concentrations of ectoine and hydroxyectoine,
cells from 1 mL culture were harvested by centrifugation (13000×g, 5 min, 4 ◦C).
The exact sample volume was determined gravimetrically on an analytical balance
(CP255D, Sartorius, Göttingen, Germany). In parallel, the optical density was
measured to quantify the harvested biomass amount. The supernatant was decanted,
and the cells were subsequently dried for 12 h in a speedvac apparatus (Concentrator
5301, Eppendorf, Hamburg, Germany). Cells were re-suspended in 500 µL Bligh &
Dyer solution (MeOH:CHCl3:H20, 10:5:2) and disrupted mechanically (FastPrep R©-
24, 3 min, 4 m s-1, MP Biomedicals, Santa Ana, CA, USA) using glass beads with a
diameter of 0.04 mm. The disruption step was repeated, after adding 130 µL H2O
and 130 µL chloroform to the slurry. Phases were then separated by centrifugation
(10000×g, 15 min centrifuge 5415R, Eppendorf, Hamburg, Germany). The aqueous
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phase was transferred into a novel reaction tube and subsequently evaporated to
dryness in a speedvac apparatus. The remaining solids were dissolved in 80-100 µL
H2O and centrifuged (15 min, 10000×g, 4 ◦C); metabolite concentrations were then
quantified by HPLC analysis (see section 3.6.3). Sampling for quantification of the
intracellular amino acid concentration was performed by fast filtration as described
in the literature [26].
3.6.2 Quantification of cell concentration
The concentration of cells was determined by measurement of the optical density of
the culture broth at 660 nm in plastic cuvettes (Sarstedt, Nümbrecht , Germany) and
water as a zero-value. For E. coli cells, a wave length of 600 nm was used. For optical
densities, determined with the Libra S11 instrument (Biochrome, Cambridge, UK),
the correlation between optical density and cell dry weight was 0.255 gcdw L-1 OD-1,
as reported in earlier work [11]. For determining the corresponding correlation
for a UV-1600PC spectrophotometer (VWR, Radnor, PA, USA), cells were cultivated
in 200 mL chemically defined medium in 2 L baffeled shake flasks after two pre-
cultures on BHI and defined medium as described before. At different time points,
10-14 mL of broth were withdrawn into pre-weighed reaction tubes, centrifuged
(10 min, 9800×g) and washed three times with deionized water. The cell pellets were
then dried until weight constancy (about 72 h), cooled to room temperature in an
desiccator and then weighed. The resulting correlation factor was 0.39 gcdw L-1 OD-1
(30 ◦C) and 0.34 gcdw L-1 OD-1 (38-40 ◦C).
3.6.3 Quantification of metabolites
Glucose, trehalose and organic acids were quantified by HPLC (Agilent 1260 Infinity
Series, Agilent Technologies, Waldbronn, Germany), using a Microgard pre-column
(Cation+ H+ 30x4.6, Bio-Rad, Hercules, CA, USA) and an Aminex HPX-87H main
column (Bio-Rad) as solid phase, 5 mM H2SO4 (55 ◦C, 0.7 mL h-1) as mobile phase
and quantification via external standards and refraction index detection (Agilent
Technologies, Waldbronn, Germany). Alternetively, xylose, glucose, fructose and
sucrose were quantified in diluted cultivation supernatant with HPLC (LaChromElite,
Hitachi, Chiyoda, Japan) on a Meta-Carb 87C carbohydrate column (300×7.8,
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Varian Inc., Palo Alto, CA, USA) at 85 ◦C with de-ionized water as mobile phase (0.6
mL min-1) and detection via refraction index. At-line analysis of glucose during shake-
flask experiments for ectoine production and of xylose during fed-batch cultivations
was performed by enzymatic quantification of the sugars in 1:10 diluted supernatant
samples using the biochemical analyzer YSI 2700 Select (YSI, Yellow Springs, OH,
USA).
Amino acids were quantified by HPLC (Agilent 1200 Series, Agilent Technolo-
gies, Waldbronn, Germany) on a reverse phase column (Gemini5u, Phenomenex,
Aschaffenburg, Germany) with fluorescence detection, after pre-column derivatiza-
tion with o-phthalaldehyde [116]. A gradient of eluent A (40 mM NaH2HPO4, pH
7.8) and B (45 % acetonitrile, 45 % methanol, 10 % water) served as mobile phase.
Quantification involved α-aminobutyric acid as internal standard [103]. In samples
from fed-batch production on xylose, lysine was quantified by HPLC (LaChromElite,
Hitachi, Chiyoda, Japan) on an Ionospher 5C column (100×3, Varian Inc., Palo
Alto, CA, USA) at 40 ◦C, a flow rate of 1.5 mL min-1 (20 mM tartaric acid, 4.9 mM
ethylenediamine, 1.8 mM citric acid in 95 % H2O and 5 % methanol) and detection
via refraction index. For lysine, mass concentrations given refer to lysine·HCl.
Ammonium was quantified in diluted supernatants by HPLC (ICS-2000, IonPac
CS16 column, IonPac CG16 pre-column, Dionex, Sunnycale, CA, USA) at a flow
of 0.5 mL min-1 at 40 ◦C with methansulfonic acid as mobile phase. Detection
was performed by a conductivity detector (L7470, LaChromElite, Hitachi, Chiyoda,
Japan).
Quantification of ectoine and hydroxyectoine was performed by HPLC analysis
(LaChrome, Merck-Hitachi, Darmstadt, Germany) using a ProntoSil C18 AQ + col-
umn (125×4 mm, Knauer, Berlin, Germany) with a Nucleosil C18 AQ + pre-column
(120×5 mm, Knauer, Berlin, Germany). As mobile phase, a phosphate buffer was
used (0.8 mM K2HPO4; 6.0 mM Na2HPO4, pH 7.6) at a flow rate of 1 mL min-1 and
at 40 ◦C. The injection volume was 2 µL. Detection was carried out with a diode
array detector (L7450, LaChrome, Merck-Hitachi, Darmstadt, Germany) at 220 nm.
3.6.4 Enzymatic assays
For preparation of a cell extract, cells, cultivated on minimal salt medium, were
harvested by centrifugation (5 min, 9800×g, 4 ◦C), washed with disruption buffer
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[97] and re-suspended in the same buffer to a final concentration of 0.25 gcww mL-1.
In a reaction cup, filled with 0.5 mL of glass beads (0.15-0.25 mm ∅), 1 mL of
the suspension was then disrupted using a homogenizer (4 m s-1, 2×30 s with a
5 min break in between, FastPrep-24, MP Biomedicals, Santa Ana, CA, USA). Cell
debris was removed by centrifugation (5 min, 14000×g, 4 ◦C). The protein content
of the obtained extract was measured with a bicinchoninic acid (BCA) protein assay
(Thermo Fisher Scientific, Rockford, MA, USA).
Xylose isomerase activity was determined in a reaction mixture that contained 50
mM Tris-HCl (pH 7.4), 10 mM MgCl2, 0.15 mM NADH, 0.5 U mL-1 sorbitol dehyd-
rogenase (Roche, Basel, Switzerland), 50 mM xylose and 20 µL crude cell extract
[56, 215]. Xylulokinase activity was measured in a reaction mixture that contained
50 mM Tris-HCl (pH 7.5), 2 mM MgCl2, 2 mM ATP, 0.2 mM phosphoenolpyruvate,
0.2 mM NADH, 10 U mL-1 pyruvate kinase (Sigma-Aldrich, St. Lois, MO, USA), 10
U mL-1 lactate dehydrogenase (Sigma-Aldrich, St. Lois, MO, USA), 13 mM xylulose
and 0.5 µL crude cell extract [51]. Diaminopimelate dehydrogenase activity was
determined in a reaction mixture that contained 200 mM glycine (pH 10.5), 10 mM
MgCl2, 2 mM NADP, 4 mM meso-diaminopimelate and 50 µL crude cell extract [39].
Quantification of the activity was realized by measuring the change of NADH
absorption at 340 nm (Sunrise, Tecan, Männedorf, Switzerland). It was converted to
enzymatic units, i.e. the amount of enzyme that catalyzes the reaction at a rate of 1
µmol min-1.
3.6.5 Mass spectrometry
Labeling patterns of proteinogenic amino acids and of secreted trehalose, required
for calculation of metabolic fluxes, were determined from the proteinogenic amino
acids and from the secreted trehalose by GC-MS [100]. Sample preparation and
measurements were carried out as described previously [26], using the GC system
7890A gas chromatograph and a quadrupole MS detector (inert MSD 5979C, Agilent
Technologies, Waldbronn, Germany). The 13C labeling patterns were determined
from three samples, which were taken at different time points during cultivation, to
verify the isotopic steady-state. The mass spectra of alanine, valine, threonine, as-
partate, glutamate, serine, phenylalanine, glycine and tyrosine from the cell proteins
and of the trehalose from the culture supernatants, which were corrected for the
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natural abundance of all stable isotopes then served as input for the flux calculation.
3.6.6 Metabolic flux analysis
Metabolic flux calculation was performed by Judith Becker at the Institute of Systems
Biology at the Saarland University. The metabolic network for flux estimation
comprises the central metabolism with glycolysis, the pentose phosphate pathway, the
tricarboxylic acid cycle and the glyoxylate shunt. All reactions for the interconversion
of the three-carbon metabolites of glycolysis and the four-carbon metabolites of
the TCA cycle present in C. glutamicum Lys12 as well as typical by-product-forming
pathways were included.
For flux estimation, the metabolic network of C. glutamicum was implemented in
the open source software OpenFlux [34, 167]. The software was extended to handle
13C labeling data from the two parallel experiments by changing the subroutines
‘leastSQ’ and ‘mdvGenerator’ (Fig. 37 in the appendix). In addition, the specification
file, reflecting the parallel labeling experiments (‘inputSubEMU.mat’), was adapted
accordingly, using the guided substrate input specifications [166].
Directly measured fluxes from three biological replicates (glucose uptake, form-
ation of biomass, lysine and by-products) were used to calculate the free fluxes in
the metabolic network of C. glutamicum Lys12 [34, 167]. The set of fluxes that gave
the minimal deviation between the experimental and the simulated mass isotopomer
fractions considered to be the best calculation of the intracellular flux distribution.
For error considerations, a weighted sum of least-squares was applied [229]. The
labeling data were corrected for the natural labeling of the inoculum and for nat-
ural isotopes [228]. Statistical analysis providing 90 % confidence intervals of the
estimated fluxes was carried out by Monte-Carlo approach [167, 233].
3.7 Calculation of production parameters
3.7.1 Yields and rates
For calculation of yields during cultivations, the amount of product (Ptn) formed and
substrate (Stn) utilized for each sample time tn was calculated. The term product
applies to biomass as well as to any metabolite formed. For simple shake flask
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cultivations at low temperatures, i.e. cultivations in chapters 4.3 and 4.2, equations
2 and 3 were used. Hereby, cP,tn denotes the concentration of the product at time tn;
the denomination of the substrate concentration followed suit.
Ptn = cP,tn− cP,t0 (2)
Stn = cS,t0− cS,tn (3)
For cultivations where the broth volume (Vt) significantly changed due to factors other
than sampling, i.e. all fed-batch cultivations and shake flask cultivations in chapter
4.1, where evaporation was considered due to higher temperatures, equations 4 and
5 were used
Ptn =Vtn · cP,tn−Vt0 · cP,t0 +
tn
∑
n=t0
(Vsample,n · cP,n) (4)
Stn =Vt0 · cS,t0−Vtn · cS,tn−
tn
∑
n=t0
(Vsample,n · cS,n) (5)
In all cases, the yield was determined by linear regression according to equation 6.
YP
S ,tn
=
tn
∑
n=t0
Pn ·Sn
tn
∑
n=t0
S2n
(6)
Product per biomass yield YP
X ,t
for the calculation of specific product formation rate
(see equation 9) were calculated using equation 7.
YP
X ,tn
=
tn
∑
n=t0
Pn ·Xn
tn
∑
n=t0
X2n
(7)
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For the calculation of the maximum specific growth rate µmax, equation 8 was used.
Here, the amount of biomass Xt was calculated according to equation 2 or 4 and
nt represents the amount of sample points used for the calculation. Like equation
6, equation 8 also a linear regression, but for the calculation of µmax only samples
considered to be within the period of exponential growth were included, not all
samples.
µmax,tn =
n ·
tn
∑
n=t0
(ln(Xn) ·n)−
tn
∑
n=t0
n ·
tn
∑
n=t0
(ln(Xn))
n ·
tn
∑
n=t0
n2−
(
tn
∑
n=t0
n
)2 (8)
Specific rates of product formation (qP) and substrate uptake (qS) were calculated
according to equation 9 and 10, respectively.
qP,tn = µmax,tn ·
P, tn
X , tn
(9)
qS,tn =
µmax,tn
YX
S ,tn
(10)
3.7.2 NADPH supply and demand
Following the stoichiometry of lysine production (chapter 2.1.2, Fig. 7) and the
metabolic routes in C. glutamicum (Fig. 6), equations 11 and 12 were used to
calculate the NADPH supply and demand respectively.
SupplyNADPH = vMalE + vIcd + vZwf + vGnd (11)
DemandNADPH = 4× vLysA + vBiomass×16.429mmolg (12)
The corresponding genes and names to the enzymes, abbreviated here, can be found
in the list on page vi. The NADPH demand for biomass production is taken from
[231].
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3.7.3 Economic parameters
For the assessment of the economic effects of different cultivation temperatures
(chapter 4.1), equations 13 and 14 were used to calculate revenues. Equation 13
hereby represents the fundamental concept and equation 14 the more mathematical
notation, showing that in addition to the market prices of the substrate and product
also the product yield, the operational cost of the production plant and the production
rate play a role.
Revenue = {Market priceProduct}−{CostSubstrate}−{Operational cost} (13)
Revenue =
[
e
molLys
]
−
[
e
molGluc
·YS
P
]
−
[
e
L·h
molLys
L·h
]
(14)
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RESULTS AND DISCUSSION
4.1 Lysine production of C. glutamicum at elevated
temperature
4.1.1 Growth and product formation
Temperature is one of the most fundamental process parameters in microbiology
and biotechnology. While it appears straightforward in research to keep cultivation
conditions constant in order to enable the comparison of different experiments,
traditionally used parameters might not be desirable for production performance.
Almost all cultivations with C. glutamicum have been performed at a temperature
around 30 ◦C [98]. However, it has been reported that certain strains may show
increased production performance at higher temperature [149]. In this regard, first
studies should investigate underlying metabolic responses to temperature in order
to eventually identify mechanisms for an enhancement of production and further
improvement of industrial applications of C. glutamicum.
The C. glutamicum strains under investigation comprised the entire range with
regard to lysine production, including the wild type C. glutamicum ATCC 13032, the
basic lysine producer C. glutamicum Lys1 and the hyper-producing strains C. glu-
tamicum Lys12 and Lys12K (Tab. 2, Fig. 10). C. glutamicum ATCC 13032 hereby
is the predecessor of all the strains, strain Lys1 displays lysine secretion due to
the decoupling of the enzyme aspartokinase from metabolic feedback inhibition.
The genome of the hyper-producers C. glutamicum Lys12 and Lys12K have been
engineered on a systems-wide level to allow for optimized lysine production [18].
The latter strain additionally possesses the empty plasmid pClik 5a MCS as further
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Fig. 12: Screening of C. glutamicum Lys12K growth and lysine production properties over a
range of temperatures in shake flasks. The data were corrected for evaporation and sampling
and the error bars represent the standard deviation of two flasks (for 30 and 40 ◦C four and
three flasks, respectively).
metabolic burden (Tab. 2).
An initial screening study investigated the impact of temperature on the growth
physiology of a highly advanced lysine producer in a range from the conventional
value 30 to 40 ◦C. C. glutamicum Lys12K, the strain with the highest metabolic
burden, was chosen for the first experiments as it was expected to be most sensitive to
environmental changes. Growth experiments in shake flasks revealed a considerable
temperature robustness of the strain (Fig. 12). Fastest growth of Lys12K occurred
at 30 ◦C, but the strain was capable to grow up to 40 ◦C, the highest temperature
tested. In contrast to a decreased growth efficiency, lysine production was enhanced
at higher temperature. The lysine yield at 40 ◦C (0.44 mol mol-1) was 55 % higher
than that at 30 ◦C (0.28 mol mol-1). The process productivity showed a maximum at
35.5 ◦C.
For three temperatures, 30, 38 and 40 ◦C, shake flask cultivations were performed
of the four strains mentioned above and the robust performance at higher temperat-
ure was also observed for them (Tab. 6). Generally, higher temperature positively
influenced lysine production at the expense of growth, i.e. biomass yield and specific
growth rate. To some extent, the studied strains differed in their quantitative re-
sponse to the imposed temperature. All lysine producing strains showed an increase
in the lysine yield of about 40-50 % with a temperature increase from 30 to 38 ◦C.
However, the highest temperature tested (40 ◦C) was only beneficial for lysine in
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Table 6: Impact of cultivation temperature on growth kinetics and stoichiometry in the wild
type C. glutamicum ATCC 13032 and lysine producing strains C. glutamicum Lys1, Lys12
and Lys12K, all grown on glucose minimal medium. The data comprise yields for the main
products lysine (YLys/Glc) and biomass (YX/Glc), maximum specific growth rate (µmax) and
yields for by-products trehalose (YTre/Glc), succinate (YSuc/Glc) and glycine (YGly/Glc) and
reflect mean values and deviations from three biological replicates (for Lys12K 30 and 38 ◦C
four and two replicates, respectively). The underlying concentration measurement data are
corrected for evaporation and sampling.
Strain Temp. µmax YX/Glc YLys/Glc YTre/Glc YSuc/Glc YGly/Glc
[ ◦C] [h-1] [g/mol] [mol/mol] [mmol/mol] [mmol/mol] [mmol/mol]
ATCC
13032
30 0.41±0.01 94.4±4.7 n/a 3.7±0.2 10.9±0.0 9.0±0.3
38 0.23±0.01 57.7±5.2 n/a 10.4±0.6 16.8±0.9 7.4±0.6
40 0.12±0.00 63.8±1.4 n/a 12.3±0.5 15.5±1.3 2.5±0.4
30 0.39±0.00 86.9±3.6 0.08±0.01 4.3±0.0 11.0±0.0 5.2±0.2
Lys1 38 0.31±0.00 52.7±5.8 0.12±0.00 10.5±0.7 16.6±0.5 4.2±0.2
40 0.08±0.01 37.8±1.2 0.22±0.06 15.4±1.2 12.2±0.6 1.6±1.1
30 0.24±0.01 57.9±2.6 0.27±0.02 5.7±0.9 6.0±2.0 4.0±0.7
Lys12 38 0.11±0.00 33.2±1.4 0.43±0.01 14.4±1.1 4.5±0.0 1.7±0.1
40 0.03±0.00 16.1±0.2 0.41±0.03 12.6±0.4 6.0±0.1 0.5±0.1
30 0.25±0.01 58.9±9.5 0.28±0.02 3.1±1.3 6.2±0.1 3.8±0.5
Lys12K 38 0.10±0.02 25.8±4.9 0.43±0.01 14.5±0.1 9.0±0.0 0.1±0.0
40 0.03±0.01 20.2±1.2 0.44±0.01 12.7±0.3 5.9±0.1 0.4±0.0
C. glutamicum Lys1, not for the highly engineered producers. With regard to growth,
the highly advanced lysine producers appeared more sensitive than the wild type
C. glutamicum ATCC 13032 and the basic producer C. glutamicum Lys1. The highest
lysine yield achieved in these shake flask studies amounted to almost 60 % of the
theoretical maximum of 0.75 mol mol-1 [197].
By-products formed at significant levels were trehalose, glycine and succinate (Tab.
6). The secretion of the disaccharide trehalose increased with higher temperature.
In contrast, glycine formation was reduced as temperatures increased, whereby the
relative changes differed among the strains to a varying degree. Succinate secretion
did not follow a temperature-specific pattern but remained within a similar range for
each strain. Leucine was secreted only by C. glutamicum ATCC 13032 at elevated
temperatures to levels of 46 and 75 µM at 38 and 40 ◦C respectively. Glutamate
was formed at levels above 10 µM only at the highest temperature of 40 ◦C to
concentrations of 45, 30, 52 and 18 µM for C. glutamicum ATCC 13032, Lys1, Lys12
and Lys12K, respectively. The increased levels of trehalose and glutamate at elevated
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Fig. 13: Quantitative physiological characterization of C. glutamicum Lys12 grown at 30 and
38 ◦C. A: Linear correlation of produced biomass and lysine relative to the amount of glucose
consumed by the cells. B: Exponential biomass production over the relevant time window of
the cultivation. The correlations show the metabolic steady state during exponential growth
of the cells.
temperatures are easily understood as those two compounds are known compatible
solutes and synthesized by C. glutamicum under temperature stress conditions [43,
55, 85]. The observed change in growth and product formation was a clear indication
for an altered physiology in the studied strains.
4.1.2 Intracellular metabolic fluxes
Flux calculation and NADPH balance. The clear effect on growth and production
suggested a temperature dependent metabolic shift towards a production-favorable
carbon utilization. To assess the intracellular flux distribution, C. glutamicum Lys12
was grown on [1-13C] glucose as well as on an equimolar mixture of [U-13C] glucose
and naturally labeled glucose in parallel. Subsequent GC/MS analysis of secreted
trehalose and of amino acids (alanine, valine, threonine, aspartate, glutamate, serine,
phenylalanine, glycine and tyrosine) from hydrolyzed cell protein delivered precise
13C labeling data (Tab. 7).
The obtained experimental data were used to calculate metabolic flux distributions
for each temperature (Fig. 15 and 16). The set of intracellular fluxes that gave the
minimum deviation between experimental and simulated labeling patterns was taken
as best estimate for the intracellular flux distribution. For both studied temperatures,
identical flux distributions were obtained with multiple starting values for the flux
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Table 7: Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein
and the secreted trehalose from C. glutamicum Lys12, grown at 30 and 38 ◦C in 99% [1-
13C] glucose and in an equimolar mixture of naturally labeled glucose and 99% [U-13C]
glucose. Data denote experimental GC-MS data (exp) and calculated labeling patterns (calc),
corresponding to the optimal flux fit. The mass isotopomer m represents the relative amount
of non-labeled isotopomer, m+1 represents the amount of singly labeled mass isotopomer
fraction and so on. Amino acids and trehalose were analyzed by GC/MS as trimethyldi-
methylsilyl derivatives and as trimethylsilyl derivate, respectively. The considered ion cluster
for each compound is denoted by the m/z value of its mono-isotopic mass. (Table continued
on page 50)
1-13C U-13C
30 ◦C 38 ◦C 30 ◦C 38 ◦C
exp calc exp calc exp calc exp calc
Ala m/z 260
(Alanine)
m 0.582 0.588 0.605 0.610 0.358 0.355 0.353 0.351
m+1 0.300 0.296 0.281 0.278 0.149 0.145 0.157 0.155
m+2 0.094 0.093 0.092 0.090 0.123 0.121 0.133 0.132
Val m/z 288
(Valine)
m 0.455 0.457 0.493 0.494 0.166 0.156 0.169 0.154
m+1 0.356 0.357 0.336 0.338 0.092 0.088 0.101 0.098
m+2 0.140 0.138 0.127 0.126 0.220 0.219 0.217 0.219
Thr m/z 404
(Threonine)
m 0.392 0.386 0.421 0.421 0.165 0.166 0.193 0.189
m+1 0.357 0.360 0.346 0.346 0.202 0.195 0.201 0.196
m+2 0.172 0.174 0.162 0.162 0.199 0.195 0.183 0.181
Asp m/z 418
(Aspartate)
m 0.390 0.386 0.418 0.420 0.164 0.166 0.192 0.189
m+1 0.356 0.359 0.345 0.345 0.201 0.194 0.201 0.195
m+2 0.174 0.175 0.164 0.162 0.204 0.195 0.184 0.181
Glu m/z 432
(Glutamate)
m 0.316 0.317 0.354 0.356 0.088 0.084 0.108 0.096
m+1 0.358 0.363 0.353 0.356 0.130 0.120 0.128 0.122
m+2 0.209 0.206 0.192 0.189 0.231 0.235 0.242 0.253
Ser m/z 390
(Serine)
m 0.514 0.510 0.533 0.525 0.318 0.319 0.295 0.300
m+1 0.315 0.317 0.301 0.306 0.177 0.174 0.196 0.191
m+2 0.131 0.131 0.127 0.129 0.149 0.148 0.180 0.184
Phe m/z 336
(Phenylalanine)
m 0.390 0.385 0.424 0.420 0.056 0.054 0.067 0.054
m+1 0.366 0.367 0.352 0.355 0.053 0.049 0.058 0.054
m+2 0.170 0.173 0.156 0.159 0.091 0.092 0.090 0.095
parameters, suggesting that global minima were identified in the examined cases.
Excellent agreement between experimentally determined and calculated mass iso-
topomer ratios was achieved for both examined conditions (Tab. 7) and metabolic
(Fig. 13) and isotopic (Fig. 14) steady state could be validated.
The NADPH supply calculations (equations 11 and 12) in the 13C cultivations from
the fluxes and the Monte-Carlo approach showed an NADPH supply of 2.28±0.17
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Table 7: (Continued from page 49) Relative mass isotopomer fractions of amino acids from
hydrolyzed cell protein and the secreted trehalose.
1-13C U-13C
30 ◦C 38 ◦C 30 ◦C 38 ◦C
exp calc exp calc exp calc exp calc
Gly m/z 246
(Glycine)
m 0.752 0.751 0.749 0.743 0.384 0.378 0.387 0.381
m+1 0.176 0.177 0.179 0.185 0.187 0.190 0.196 0.196
Tyr m/z 466
(Tyrosine)
m 0.336 0.332 0.363 0.362 0.050 0.047 0.061 0.047
m+1 0.351 0.355 0.342 0.349 0.053 0.049 0.059 0.052
m+2 0.195 0.200 0.183 0.187 0.087 0.087 0.087 0.090
Tre m/z 361
(Trehalose)
m 0.155 0.149 0.180 0.179 0.295 0.287 0.271 0.269
m+1 0.550 0.554 0.528 0.531 0.122 0.120 0.123 0.122
m+2 0.187 0.188 0.186 0.185 0.091 0.096 0.100 0.104
Ala m/z 232
(Alanine)
m 0.613 0.620 0.639 0.643 0.411 0.407 0.408 0.404
m+1 0.297 0.292 0.275 0.272 0.148 0.141 0.161 0.158
m+2 0.090 0.088 0.086 0.085 0.441 0.452 0.431 0.437
Val m/z 260
(Valine)
m 0.463 0.472 0.503 0.511 0.186 0.178 0.188 0.176
m+1 0.354 0.354 0.334 0.333 0.096 0.089 0.108 0.104
m+2 0.135 0.131 0.122 0.118 0.377 0.384 0.364 0.373
Thr m/z 376
(Threonine)
m 0.422 0.415 0.451 0.447 0.196 0.192 0.227 0.219
m+1 0.356 0.360 0.342 0.345 0.257 0.246 0.244 0.237
m+2 0.165 0.167 0.154 0.155 0.296 0.308 0.303 0.321
Asp m/z 390
(Aspartate)
m 0.422 0.415 0.445 0.446 0.195 0.192 0.226 0.218
m+1 0.354 0.359 0.340 0.344 0.253 0.246 0.241 0.236
m+2 0.166 0.168 0.158 0.156 0.295 0.308 0.301 0.322
Glu m/z 330
(Glutamate)
m 0.451 0.448 0.478 0.487 0.160 0.149 0.176 0.156
m+1 0.361 0.359 0.333 0.340 0.144 0.127 0.137 0.128
m+2 0.148 0.143 0.135 0.129 0.333 0.345 0.338 0.348
Ser m/z 362
(Serine)
m 0.551 0.545 0.571 0.563 0.372 0.371 0.349 0.351
m+1 0.320 0.324 0.304 0.310 0.194 0.187 0.244 0.242
m+2 0.129 0.131 0.125 0.127 0.435 0.442 0.407 0.406
Phe m/z 234
(Phenylalanine)
m 0.440 0.442 0.480 0.483 0.070 0.067 0.079 0.067
m+1 0.370 0.375 0.352 0.357 0.057 0.052 0.063 0.059
m+2 0.140 0.141 0.125 0.125 0.155 0.158 0.149 0.158
Gly m/z 218
(Glycine)
m 0.827 0.826 0.825 0.822 0.465 0.456 0.473 0.463
m+1 0.173 0.174 0.175 0.178 0.535 0.544 0.527 0.537
Ser m/z 288
(Serine)
m 0.597 0.596 0.620 0.615 0.392 0.393 0.368 0.373
m+1 0.305 0.308 0.286 0.291 0.177 0.168 0.231 0.229
m+2 0.098 0.097 0.094 0.094 0.431 0.441 0.401 0.400
Phe m/z 302
(Phenylalanine)
m 0.731 0.716 0.728 0.713 0.386 0.368 0.389 0.372
m+1 0.194 0.206 0.196 0.209 0.200 0.201 0.209 0.208
Asp m/z 316
(Aspartate)
m 0.461 0.457 0.490 0.492 0.209 0.206 0.242 0.235
m+1 0.355 0.362 0.337 0.343 0.259 0.249 0.243 0.237
m+2 0.139 0.141 0.130 0.129 0.290 0.305 0.297 0.320
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Fig. 14: Mass-charge ratio of different amino acids at different biomass concentrations during
the cultivation of C. glutamicum Lys12 on 13C glucose showing the isotopic steady-state of the
cultivation. A: 30 ◦C with [1-13C] glucose, B: 30 ◦C with an equimolar [13C6] and naturally
labeled glucose mixture, C: 38 ◦C with [1-13C] glucose, D: 38 ◦C with an equimolar [13C6]
and naturally labeled glucose mixture. alanine, valine, threonine, glutamate, serine,
phenylalanine, glycine,
and 2.97±0.08 molNADPH molGlucose-1 at 30 and 38 ◦C, respectively. On the demand
side, the values were 2.03±0.12 molNADPH molGlucose-1 at 30 ◦C and 2.23±0.07
molNADPH molGlucose-1 at 38 ◦C. This means a supply to demand ratio of 1.12 at 30 ◦C
of 1.33 at 38 ◦C. This ratio not being closed, but above the value of 1, indicates that
not all biochemical reactions have been taken into account. On the demand side,
this could be caused by the factor for the NADPH demand of biomass production
in our set up possibly being lower than the one taken from the literature and used
in equation 12. As NADPH is involved in the generation of nucleic and fatty acids
[195], higher molecular turnover and changes in the cell-membrane composition
[32] might explain the even higher NADPH-excess at elevated temperatures. On the
supply side the only of the major NADPH-generating enzymes [195] not considered
in the calculation of the balance (equation 11) is the polyphosphate/ATP-dependent
NAD kinase (EC:2.7.1.23) [129]. Due to the already existing apparent over supply, a
strong generation of NADPH by this enzyme is unlikely. Fundamentally, the supply
to demand ratio exceeding a value of 1 shows that carbon fluxes as calculated can
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well account for the extensive demand in redox power put forward by lysine yields
as high as the ones seen in C. glutamicum Lys12.
Metabolic fluxes through glycolysis and pentose phosphate pathway. At the ref-
erence temperature of 30 ◦C, C. glutamicum Lys12 channeled 86 % of the consumed
glucose into the PP pathway (Fig. 15), which is in good accordance with previous
estimates [18]. The PP pathway flux could be determined with high precision, which
becomes evident from the narrow 90 % confidence interval. The metabolically im-
portant branching point between glycolysis and PP pathway hence was reflected
sensitively in the labeling data. At elevated temperature, cells metabolized glucose
via the PP pathway even more than at 30 ◦C. The relative flux was as high as 101 %
(Fig. 16). Thus, cells almost exclusively channel the substrate into the PP pathway,
despite the EMP route being fully functional.
The strong connection between the oxidative part of the PP pathway and lysine
production has been pointed out in the introduction (chapter 2.1.1) and is based on
the high NADPH demand during the bio-synthesis of the amino acid, as the synthesis
of one molecule of lysine requires 4 molecules of NADPH. The integrated inspec-
tion of 13C metabolic flux data from this work with that of other lysine-producing
strains even suggests a direct correlation of flux through the PP pathway and lysine
biosynthesis (Fig. 17). Consequently, metabolic engineering efforts largely have
been aimed at increased carbon flux through the PP pathway. For example, replace-
ment of the PP pathway enzymes glucose 6-phosphate dehydrogenase (G6PDH) and
6-phosphogluconate dehydrogenase (6PGDH) by mutated variants with superior
kinetic properties successfully pulled extra carbon into the PP pathway and increased
lysine production [10, 152]. In addition, the pushing of carbon into the PP path-
way through over expression of gluconeogenic fructose 1,6-bisphosphatase (FBP)
improved lysine production in C. glutamicum [13].
An interesting approach in this direction reported on a disrupted glycolysis through
elimination of phosphoglucoisomerase, which forced C. glutamicum to completely
convert glucose via the PP pathway [135]. Unfortunately, such PGI null mutants
exhibit imbalanced growth and production. It is clear from the non-uniformity of
the trehalose labeling and the overall existing labeling information from [1-13C]
glucose presented in this work, that a significant inter-conversion of glucose 6-
phosphate and fructose 6-phosphate was present. The reason behind this is, that the
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100
Fig. 15: In vivo activity of the central metabolic pathways of C. glutamicum LYS12 at 30 ◦C.
(Caption continued on next side.)
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Fig. 15: (Caption continued from previous side). In vivo activity of the central metabolic
pathways of C. glutamicum LYS12 at 30 ◦C during growth on glucose. All fluxes are given as
molar percentage of the specific glucose uptake rate of 4.1±0.15, which was set to 100 %. An
arrow indicates the direction of the net flux of reversible reactions. Statistic evaluation was
carried out by Monte-Carlo analysis. The errors reflect the corresponding 90 % confidence
intervals for the different fluxes. AcCoA = acetyl CoA, AKG = α-ketoglutarate, BM =
biomass, DAP = diaminopimelate, DHAP = dihydroxyacetone phosphate, E4P = erythrose
4-phosphate, F6P = fructose 6-phosphate, GAP = glyceraldehyde 3-phosphate, Glyex =
extracellular glycine, G6P = glucose 6-phosphate, ICI = isocitrate, Lys = lysine, Lysex =
extracellular lysine, MAL = malate, OAA = oxaloacetic acid, PEP = phosphoenolpyruvate,
PGA = 3-phosphoglycerate, Pyr = pyruvate, P5P = pentose 5-phosphate, SUC = succinate,
SUCex = extracellular succinate, S7P = sedoheptulose 7-phosphate, Treex = extracellular
trehalose.
6-phosphoglucoisomerase dehydrogenase decarboxylates 6-phosphoglucoisomerase
at the isotopically labeled C1 atom when [1-13C] is used, thus eliminating any la-
beling information, unless said reversibility of the phosphoglucoisomerase is active.
This also underlines the high flexibility of the metabolic routes to adapt to environ-
mental changes. In addition to this obvious importance of phosphoglucoisomerase
to fine-tune metabolism, pathway simulations provide evidence that deletion of this
enzyme should not be the first choice to reach high PP pathway fluxes, because
optimal lysine production needs this enzyme to re-cycle carbon from lower parts
of metabolism back into the PP pathway [109, 140]. This re-directing of carbon is
exactly what happened in the 38 ◦C cultivations of C. glutamicum Lys12 (Fig. 16), a
strain metabolically designed for optimized lysine production. The combination of
bioprocess and metabolic engineering hence led to the highest flux through the PP
Fig. 16: (Figure on next side). In vivo activity of the central metabolic pathways of C. glu-
tamicum LYS12 at 38 ◦C during growth on glucose. The color of the arrows indicate the
deviation of the in vivo fluxes in positive (green,solid) or negative (red, hatched) direction
from the theoretical optimum for lysine production [34, 140], when compared to the fluxes
at 30 ◦C. For the flux from the PEP/Pyr to the OAA/Mal pool marked with an asterisk, the
flux is closer to the theoretical optimum only when the net-flux between those metabolite
pools is considered. All fluxes are given as molar percentage of the specific glucose uptake
rate of 3.9±0.17 mol g-1 h-1 which was set to 100 %. An arrow indicates the direction of the
net flux of reversible reactions. Statistic evaluation was carried out by Monte-Carlo analysis.
The errors reflect the corresponding 90 % confidence intervals for the different fluxes. The
same abbreviations as in Fig. 15 were used.
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Fig. 16: (Caption on previous side.) In vivo activity of the central metabolic pathways of
C. glutamicum LYS12 at 38 ◦C.
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Fig. 17: Correlation between the carbon fluxes through the pentose phosphate pathway
and towards lysine production determined with 13C-Flux analysis in different strains of
C. glutamicum. This work, [13], [10], [12], [18], [232], [100], [117],
[234], [101], [136] [158].
pathway ever reported for C. glutamicum and as a consequence to the highest lysine
yield ever achieved. Reaching lysine yields even closer to the theoretical maximum
would require even higher PP pathway fluxes [109, 140].
Fluxes at the pyruvate node. The pyruvate node in C. glutamicum comprises a
number of reactions (chapter 2.1.1), but the outline of the labeling experiments in this
work allowed only for the resolution of net-fluxes between the oxaloacetate/malate
(OAA/Mal) and the phosphoenolpyruvate/pyruvate (PEP/Pyr) pool. The carbon
re-cycling, which occurs at both temperatures, is much stronger at 38 ◦C. In both
experimental set-ups, the net-flux led from the PEP/Pyr pool to the OAA/Mal pool,
namely 43.9 % and 51.5 % for 30 and 38 ◦C, respectively. The flux at the higher
temperature was hence closer to the optimal theoretical value of 75 % [109, 140]. At
38 ◦C, a lower flux from pyruvate to acetyl-CoA occurs. The incorporation or release
of CO2 taking place in the anaplerotic reactions with regard to biomass formation
will be discussed later in this chapter.
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Metabolic fluxes through the TCA cycle. The tricarboxylic acid (TCA) cycle exhib-
ited fully cyclic operation with little difference at both temperatures as shown e.g. by
the entry reaction into the TCA cycle, citrate synthase (34.6 % at 30 ◦C and 30.4 %
at 38 ◦C). This carbon flux was rather low compared to other C. glutamicum strains,
including the predecessors of Lys12 [18]. Of those predecessor strains, the last 5
modifications implemented (in order: C1372T pyc, Psodpyc, A1G icd, Ptuf fbp, Psodtkt)
all led to reduced flux through the TCA cycle as well as to higher fluxes through the
PP pathway and toward lysine formation [18].
Obviously, rather low amounts of carbon were available for the formation of
energy in the form of ATP at both temperatures, which is likely due to the enormous
withdrawal of the TCA cycle-derived building block oxaloacetate for lysine production
and to a lower degree due to biomass formation, competing with energy forming
reactions. The energy shortage thus was one off the reason of the reduced growth
rate at high temperature, which was particularly pronounced in these more advanced
producers (Tab. 6). At 38 ◦C the hyper-producers C. glutamicum Lys12 and Lys12K
reach only 46 and 40 % of their specific growth rate at 30 ◦C. This temperature-
dependent reduction is less drastic for the wild type strain C. glutamicum ATCC 13032
(56 %) and the basic lysine producer C. glutamicum Lys1 (79 %). With increasing
temperature, the energy demand for cellular maintenance increases [4, 64, 133].
This has a more severe effect on strains like the advanced producers, which exhibit a
lower energy metabolism already at low temperatures and need to commit a bigger
percentage of it to cellular maintenance, which led to a stronger decrease of the
specific growth rate with rising temperatures for those strains.
By-product and biomass formation. By-product formation of C. glutamicum Lys12
was low for either of the tested temperatures with only trehalose, glycine and
succinate being formed under the conditions of the flux experiments. Only the
disaccharide trehalose was secreted at higher levels at the elevated temperature, as
can be expected due to its role as a compatible solute, as mentioned earlier. Glycine
and succinate both showed higher production at 30 ◦C, yet even that amounted only
to low concentrations.
The biomass production of C. glutamicum Lys12 was reduced by over 40 % at 38 ◦C
when compared to the values at 30 ◦C (Tab. 6), which obviously also is reflected
in the carbon fluxes. One of the contributing factors to the lower biomass yield
55
Chapter 4 Results and Discussion
at higher temperatures was the stronger CO2 production. There are two carbon
dioxide creating reactions of the TCA cycle, catalyzed by the isocitrate dehydrogenase
(Icd) and oxoglutarate dehydrogenase. While the carbon flux through the latter
was equal for both temperatures, the CO2 generation by Icd was higher at 30 ◦C.
The other CO2-generating reaction where this applies, is the conversion of pyruvate
to acetyl-CoA by the pyruvate dehydrogenase. All other reactions of the central
metabolism involving CO2, namely the ones in the PP pathway (6-phosphogluconate
dehydrogenase), the lysine biosynthetic pathway (diaminopimelate decarboxylase)
and the reactions of the pyruvate node (see chapter 2.1.1) had higher (net-)fluxes
at 38 ◦C. Summed up, the carbon loss due to CO2 generation is 9 % higher at 38 ◦C
than at 30 ◦C.
All in all, the carbon loss through by-product formation in C. glutamicum Lys12 was
low at both temperatures. The higher loss due to CO2 generation and the massively
increased lysine production explain the significant reduction in biomass yield at
elevated temperature.
Correlation of fluxome to transcriptome. Fluxome analysis of the central carbon
metabolism and the lysine biosynthesis pathway of C. glutamicum Lys12 at 30 and
38 ◦C revealed differences between the two cultivation conditions. PP pathway flux
and net flux from the PEP/Pyr to the OAA/Mal pool both increased by about 20 %
and flux toward lysine by about 50 % during cultivations at the elevated temperature
(Tab. 8). On the other hand, carbon flux from pyruvate to acetyl-CoA and the
subsequent flux to α-ketoglutarate via isocitrate was reduced to 80 and 90 % of the
30 ◦C-value at 38 ◦C, respectively. Carbon flux toward biomass was decreased by
about 40 % at the higher temperature. The by-products formed showed a mixed
response to higher temperatures. While the carbon flux toward compatible solute
trehalose showed the highest relative increase of about 140 %, fluxes toward glycine
and succinate were significantly reduced at 38 ◦C (Tab. 8).
In the literature, transcriptome analysis at 30 and 40 ◦C of the C. glutamicum
ATCC 13032 based strain AHP3 is reported [149]. Like C. glutamicum Lys12, AHP3
also possesses the genomic modifications V59A hom, T311I lysC and P458S pyc, but
lacks the additional ones present in strain Lys12 (A1G icd, Ptuf fbp, Psodtkt, ∆pck,
Psodpyc, 2×ddh, 2×lysA, PsoddapB, G1A PsodlysC). These differences in the genomic
background of the two strains have to be kept in mind as it makes a direct comparison
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of the data a bit difficult. However, one could still use the combined inspection on
the effect of elevated temperature on transcriptome and fluxome as a first qualitative
glance to possibly underlying metabolic and regulatory mechanisms. Tab. 8 connects
calculated flux-ratios to the genes, whose transcription level is given in the literature.
The increase in PP pathway and lysine production fluxes are reflected by enhanced
gene expression only for a few exceptions (asd, rpi, pgl). Even though those pathways
underwent heavy genomic optimization in C. glutamicum Lys12, the increased lysine
production at elevated temperatures in strain AHP3 allow the fairly safe assumption,
that fluxes through said metabolic routes were also higher. Higher fluxes, despite
lower transcription (i.e. lower enzyme amounts) indicate a higher enzymatic activity
which could have been caused by the increased temperature.
This is different at the anaplerotic node. Flux from pyruvate and phosphoen-
olpyruvate to oxaloacetate is catalyzed by pyruvate carboxylase (pyc) and phos-
phoenolpyruvate carboxylase (ppc). The flux from the OAA/Mal to the PEP/Pyr
pool can be catalyzed by malic enzyme (malE), oxaloacetate decarboxylase (odX)
and by phosphoenolpyruvate carboxykinase (pck) in C. glutamicum AHP3, while the
latter enzyme is eliminated in C. glutamicum Lys12. Here, both the fluxes from the
PEP/Pyr to the OAA/Mal pool and the ones in the reverse direction were consider-
ably increased at high temperatures. The transcriptome analysis on the other hand
revealed, that genes involved in the catabolic direction (pyc, ppc) were expressed at
lower levels at the higher temperature while the anabolic genes (malE, pck) show an
opposite response. Transcriptome data for odX were not available. These findings
indicate that both genes, malE and odX, are potential targets for further metabolic
engineering. Even though this would mean a lower drain on the lysine precursor
oxaloacetate, in the case of malE, this would also be coupled to a lower NADPH
production, which might be negative for the production of the amino acid.
It seems, with regard to carbon core metabolism, that most changes in gene
transcription and in flux are below a factor of two, with only a few exceptions,
highlighted in Fig. 18. Besides the mentioned strong increase in flux and transcription
level of malic enzyme, it is striking that the transcription of gapA and gltA was
considerably reduced without the analogous fluxes acting accordingly. Especially
for gltA, coding for citrate synthase and hence for a reaction competing with lysine
formation, this might point to attenuation of the gene being another possible target
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Table 8: Ratios of fluxes at 38 ◦C to fluxes at 30 ◦C (RFlux), the corresponding genes and the
ratios of transcriptional levels (40 over 30 ◦C values, RTransc.) from the literature [149]. The
comments point out the difference between the strains used for fluxome analysis (C. glutami-
cum Lys12) and for transcriptone data (C. glutamicum AHP3). Gene names can be found on
page vi and in the literature [67]. Metabolite abbreviations are identical to Fig. 15. Table
continued on next side
Flux RFlux Gene RTransc. Comment
G6P→P5P 1.18
zwf 0.65
Psod(tkt,tal,zwf,opcA,pgl) in
Lys12
opcA 1.00
pgl 1.80
gnd 0.55
rpe 0.70
rpi 1.25
G6P→Tre 2.42 n/a n/a
G6P→F6P n/a pgi 0.40 flux reversed, hence no RFlux
F6P→GAP 0.94
glpX 0.90 Ptuf fbp in Lys12, fbp named
glpX in [149]
pfp 1.10
fda 0.80
GAP,S7P→E4P,F6P 1.20 tal 0.60
Psod(tkt,tal,zwf,opcA,pgl) in
Lys12P5P,E4P→F6P,GAP 1.24 tkt 0.67
2×P5P→GAP,S7P 1.20
DHAP→GAP 0.94 tpiA 0.60
GAP→PGA 0.99
gapA 0.37
gapB 0.70
pgk 0.55
PGA→PEP 1.02
gpmB 0.60
gpm 1.30
eno 0.60
Pyr→ACoA 0.78
pdhA 0.80
pdhB 0.60
lpd 0.70
PEP/Pyr→OAA/Mal 1.78 ppc 0.55 Psodpyc in Lys12pyc 0.70
OAA/Mal→PEP/Pyr 3.03
malE 2.50
∆pck in Lys12odX n/a
pck 2.00
ACoA→ICI 0.88 gltA 0.31acn 1.35
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Table 8: Table continued from previous side
Flux RFlux Gene RTransc. Comment
ICI→AKG 0.88 icd 0.70 A1G icd in Lys12
OAA/Pyr→Lys 1.48
dapA 0.80
2×ddh, 2×lysA, PsoddapB,
G1A PsodlysC in Lys12
dapB 0.55
dapC 0.70
dapD n/a
dapE 0.80
dapF 0.65
ddh 0.65
lysC 0.90
aspC 0.75
asd 1.30
lysA 0.65
Lys→Lysex 1.55 lysE 1.00
Suc→OAA 1.01
sdhB 2.43
sdhA 1.10
fumH 0.70
AKG→Suc 1.00
odhA 1.00
lpd 0.75
sucC 1.30
Suc→Sucex 0.71 n/a n/a
Gly→Glyex 0.50 n/a n/a
→BM 0.58 n/a n/a
for further engineering. However, care has to be taken as two different strains are
compared here.
4.1.3 Lysine production by C. glutamicum Lys12 at elevated
temperature
Obviously, temperature has a strong impact on the metabolism of C. glutamicum and,
in particular, on lysine production. Based on the findings, it appeared promising to
explore the increased performance of higher temperature in the relevant production
set-up of a fed-batch fermentation. To this end, C. glutamicum Lys12-cultivations
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Fig. 18: Flux changes and transcriptional changes of reactions and genes in the central
metabolism of C. glutamicum occurring with the switch from 30 ◦C to higher cultivation
temperatures (38 and 40 ◦C for flux and transcription data, respectively). Transcriptome
data are taken (and partly estimated) from the literature [149]. Values larger than 1 indicate
an at least twofold change. The flux assigned to malic enzyme in this graph might be partly
due to oxaloacetate decarboxylase, but no transcriptome data are available. Gene names are
listed on page vi.
were conducted at 30 and 38 ◦C.
C. glutamicum Lys12 was able to grow and produce L-lysine under both conditions.
For each temperature, two bioreactors were run in parallel as replicates, which
showed good agreement. At 38 ◦C, the final lysine titer was significantly increased.
After a process time of 90 hours, 119 and 127 g L-1 L-lysine were produced, at 30
and at 38 ◦C, respectively (Fig. 19). Particularly, the absolute amount of lysine
increased up to the end at 38 ◦C (Fig. 20 B), while it leveled out at 30 ◦C (Fig. 20
A). Obviously, cells retained their production capability to a higher degree at the
elevated temperature. This can also be seen from the frequency of the feed pulses
(vertical gray bars in Fig. 19), which at 38 ◦C was less reduced toward the end of
the cultivation. Glucose was added through a feed pump coupled to the dissolved
oxygen signal in the bioreactor. Hence active glucose utilization by the cells led
to faster depletion of the substrate and subsequent rapid increase of the dissolved
oxygen signal which again triggered the next feeding pulse.
At both temperatures, the initial glucose was depleted after approximately 20
hours. The pulse-wise addition of feeding solution caused the glucose concentration
never to exceed 8 g L-1 at the sampling time points. The volume of a feed-pulse was
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Fig. 19: Lysine production C. glutamicum Lys12 at 30 ◦C (A) and 38 ◦C (B). The data
represent mean values and standard deviation of 2 runs. The light gray vertical peaks show
the operation of the feed pump. The pump and DO data are exemplary taken from one of the
runs. The dashed vertical line marks the transition from batch to feed phase. Wall growth of
the cells at 38 ◦C towards the end of the cultivation made accurate determination of the cell
dry weight difficult. This can be seen from the large error bars and the sudden change of the
biomass concentration right at the end of the process.
set to prevent any given pulse to add glucose to a concentration higher than 30 g L-1.
The volume increase and hence the total amount of glucose added to the bioreactor
was higher for 30 ◦C (159 g) than for 38 ◦C (146 g) as can be seen from the broth
volume (Fig. 19) and the total glucose uptake over time (Fig. 20). The reduced
glucose consumption coupled to higher lysine production led to the overall increased
yield at 38 ◦C, as compared to 30 ◦C (Fig. 21).
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Fig. 20: Lysine production C. glutamicum Lys12 at 30 ◦C (A) and 38 ◦C (B). The absolute
values of the concentration values in Fig. 19 are shown.
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Fig. 21: Lysine yield (A: 30 ◦C, B: 38 ◦C) during fed-batch cultivation of C. glutamicum LYS12.
The dashed vertical line marks the transition from batch to feed phase. Different symbols
represent values for the two replicates.
As already reflected by the shake flask studies, less biomass was formed in the fed-
batch process at 38 ◦C. Additionally, the biomass concentration in the broth at 38 ◦C
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Fig. 22: Lysine productivity during fed-batch cultivation of C. glutamicum LYS12. The dashed
vertical line marks the transition from batch to feed phase.
declined towards the end of the process, whereas it remained constant at 30 ◦C. This
effect was likely not due to actual cell death, but rather resulted from increased wall
growth during the last period of the cultivation. At both temperatures, the specific
growth rate during the exponential growth phase was lower than expected from
the shake flask experiments (0.1 h-1 and 0.08 h-1 for 30 ◦C and 38 ◦C, respectively).
This implies that during the bioreactor cultivation, the higher temperature led to a
decrease of the specific growth rate by 20 % as compared to 54 % in shake flasks.
One possible explanation is the high initial sugar concentration of 115 g L-1 glucose
which might have led to substrate inhibition during the batch phase. In accordance,
the bioreactor cultivation at the reference temperature showed a higher lysine yield
(0.38 g g-1) than expected from the shake flask cultivations (Fig. 21 A).
The final concentration of 127 g L-1 L-lysine, produced at 38 ◦C, is among the
highest titers reported in the literature [18, 239]. The overall yield was boosted
by about 10 % to 0.42 g g-1 through the temperature increase (Fig. 21 B). The
productivity (Fig. 22) showed a similar time course for both temperatures with a
steep increase during the batch phase, a slightly reduced increase during the first
10 hours of the feeding phase followed by a constant decrease until the end of the
fermentation. While the peak productivity reached was higher at 30 ◦C (2.9 g L-1 h-1
compared to 2.7 g L-1 h-1 at 38 ◦C), the productivity during the batch phase and more
notably by the end of the feeding phase was higher for the elevated temperature.
Potential measures for further optimization of the bioprocess include the adjust-
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ment of the feed pulses towards slower feed-rates and higher volumes. This would
effectively lead to fewer pulses and hence fewer situations of glucose limitation for
the cells. Yet this approach would need to be executed with care as addition of
inhibiting amounts of the substrate also must be avoided. Another possible lever
is the initial glucose concentration, which could be optimized to allow for a more
efficient bioprocess. Lastly, a temperature gradient throughout the course of the cul-
tivation might lead to further improved performance. For this, further investigations
are needed to characterize the cellular response to such an incremental or gradual
change of the environment.
4.1.4 The metabolic response of C. glutamicum to elevated
temperature is of industrial value
Temperature is a major factor of industrial fermentation as it affects the behavior
of the microorganisms that catalyze the bioconversion. In addition, higher tem-
perature largely reduces the risk of contamination. Furthermore, it reduces the
amount of cooling water necessary to maintain constant temperature in industry
scale fermentation vessels. This is especially true in tropical regions, where typical
carbon sources for lysine production are grown [149] and many lysine production
plants are located [47]. It appears thus more economical to perform fermentations
at elevated temperature. Thereby, impact of the temperature on microbial growth
and production properties must be considered.
It has been observed that lysine producing C. glutamicum and related species
show varying growth and production performances during cultivation at 40 ◦C, as
compared to the commonly used 30 ◦C [151]. As presented in this work, increased
product yields at elevated temperature were observed for C. glutamicum Lys1 and
also for C. glutamicum Lys12 and a newly derived strain (Tab. 6). Furthermore, high
temperature was also found beneficial for fed-batch production of lysine (Fig. 19),
resulting in a high titer of 127 g L-1 and an efficient conversion of the substrate (42
g g-1). Fed-batch processes are most commonly used for biotechnological production
of lysine. For lysine, a ‘low value, high volume ’ commodity, product yield is of
crucial importance, because the substrate amounts to about 50 % of the variable
costs of production [41, 98] and a higher product yield therefore is a major economic
advantage.
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Fig. 23: Cost efficiency of identical lysine fermentations, considering the ratio of product to
raw material (sugar) cost. The solid lines represent the temperature dependence of the profit
at a given lysine-to-glucose price ratio. The bold green lines represent the upper and lower
boundaries (UB and LB, respectively) of ratios from the years 2008 to 2014. The data for the
calculation of the boundaries were taken from online resources and databases [221, 222].
The data for the profit are based on interpolated values for the yield and productivity shown
in Fig. 12 and on equation 14. Red markers are placed at the maximum value of each profit
curve. It becomes clear that at a lower ratio of value creation (i.e. a smaller profit margin),
the temperature with the greatest profitability should be rather high. In such a scenario, high
yields are preferable over fast production. The data should be taken as a qualitative trend, as
fixed costs and additional variable costs other than the profit margin are not considered.
Temperature variation enables an easy fine-tuning of key performance indicators:
shifting either to higher productivity or to higher yield. This provides manufacturers
the opportunity to quickly react to price developments on the market with an existing
production plant set-up merely by changing this one process variable, even for the
same strain. Fig. 23 visualizes this effect and shows how optimal temperature, i.e.
the most profitable temperature, depends on the lysine-to-glucose price ratio. In case
the glucose price is comparably low, the optimal temperature approaches the the
one with the highest productivity, 35.5 ◦C. If, on the other hand, the profit margin
65
Chapter 4 Results and Discussion
of glucose to lysine is low (i.e. a high glucose or/and a low lysine price), it is more
profitable to produce lysine with a higher yield. In this scenario, higher cultivation
temperatures are preferable.
The basic idea (equation 13) and the mathematical formulation (equation 14)
behind Fig. 23 are admittedly simplified. For a more reliable calculation of the
optimal temperatures, more than information about market prices of substrate and
product and the temperature dependence of the microbial production behavior would
be necessary. Additionally, detailed knowledge of engineering aspects of the different
temperatures (e.g. cooling costs) as well as of business numbers (e.g. market volume
of product) are also required. It is, however, noteworthy, that none of the profit-
maxima shown in Fig. 23 suggest a temperature close to 30 ◦C, which is often used
in scientific studies of C. glutamicum, as the optimal production temperature.
66
Chapter 4 Results and Discussion
4.2 Lysine production from xylose
4.2.1 Growth and lysine production of xylose-utilizing C.
glutamicum Xyl1
Naturally, C. glutamicum ATCC 13032 strains cannot use xylose as carbon source [24].
In order to implement xylose utilization, C. glutamicum Lys12 was transformed with
the episomal plasmid pClik5a PgroxylAB, which harbored the xylose catabolic genes
xylA and xylB from E. coli (Tab. 2). The gene xylA codes for xylose isomerase, while
xylB codes for xylulokinase. The two enzymes catalyze the conversion from xylose
to xylulose and further on to xylose 5-phosphate, an intermediate of the pentose
phosphate pathway, respectively (Fig. 28). C. glutamicum natively possesses a xylB
gene, so the heterologous expression of E. coli xylA allowed C. glutamicum to grow on
xylose [97]. The heterologous expression of both genes from E. coli also enabled the
bio-synthesis of cadaverine from hydrolyzed hemicellulose in C. glutamicum [36].
The mechanisms of xylose transport into C. glutamicum cells is not clear at this stage
[97], but there are indications for the involvement of hexose phosphotransferase
systems [219]. Additionally, an arabinose transporter coded by the C. glutamicum
31831 gene araE has been shown to enhance growth of a C. glutamicum R based
strain at low xylose concentrations [174].
The process of transferring the plasmid pClik5a PgroxylAB into C. glutamicum
Lys12 is described in chapter 3.1. The resulting strain was designated C. glutamicum
Xyl1. In contrast to its parent C. glutamicum Lys12, the novel mutant formed
colonies within two-day incubation on agar plates with xylose as sole carbon source.
Additionally, C. glutamicum Xyl1 exhibited significant activity of xylose isomerase
(119 ± 24 U gprotein-1) and xylulokinase (153 ± 11 U gprotein-1) respectively, while
the parent strain showed no activity for xylose isomerase and only a basal level for
xylulokinase (6 ± 5 U gprotein-1).
During growth on xylose minimal medium, xylose was consumed from early on
(Fig. 24 A). Cells reached a specific growth rate of 0.17 h-1 in chemically defined
medium containing xylose (Tab. 9). With decreasing levels of xylose, growth
slowed down slightly, but the carbon source was depleted completely. Additionally,
C. glutamicum Xyl1 accumulated substantial amounts of lysine. The lysine yield
(0.30 C-mol C-mol-1) was constant over time (Fig. 25 A), which indicated that about
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Fig. 24: Growth and lysine production of C. glutamicum Xyl1 on minimal medium with
xylose (A) and glucose (B) as sole carbon and energy source. The data reflect means and
deviations from three independent replicates.
30 % of substrate carbon was directed to product formation (Tab. 9). During the
cultivation, no by-products were formed to significant concentration. The strain
C. glutamicum Xyl1 produced lysine also from glucose and exhibited a molar lysine
yield of 0.35 C-mol C-mol-1 on this substrate (Fig. 24 B, Fig. 25 B). The maximum
specific growth rate on the hexose sugar was slightly higher (0.20 h-1), as compared
to growth on xylose (Tab. 9). On glucose, the disaccharide trehalose was the only
by-product detected, and reached about 50 mg L-1 at the end of the cultivation. The
maximum specific rates of substrate uptake and lysine production were similar for
both substrates. In all cases, the pH remained constant at 7.1±0.2 and the level
of the dissolved oxygen remained above 65 % of saturation, which indicated fully
aerobic growth.
To investigate whether the effects of elevated temperatures observed for glucose
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Fig. 25: Lysine yield of C. glutamicum Xyl1 on minimal medium with xylose (A) and
glucose (B) as sole carbon and energy source. The different symbols reflect data from three
independent replicates.
also apply on xylose, additional shake flask experiments were conducted at 38 ◦C
(Tab. 9). In contrast to glucose (see chapter 4.1), higher temperature reduced the
specific growth rate without increasing the lysine yield. This behavior was surprising
as the reduction in the biomass yield was similar to cultivation on glucose, but
the carbon seemed not to be re-directed towards lysine biosynthesis. A possible
explanation could be the entry point of xylose derived xylose 5-phosphate into the
central metabolism, which which is located downstream of the oxidative part of
the PP pathway. This might limit the flux increase into the PP pathway and the
concomitant increase in NADPH production (Fig. 15 and 16), which appears to play
an important role for lysine production [136, 231, 234] (Fig. 17). Additional 13C flux
analysis on xylose could shed more light into the underlying cellular mechanisms.
Hereby, the response of the increased temperature on the carbon flux through the
TCA cycle would be of particular interest. Growth on xylose under more stressful
conditions might require an increased maintenance and hence energy demand.
4.2.2 Production from xylose in a fed-batch environment
The production performance of the novel C. glutamicum Xyl1 strain on xylose-based
medium was next investigated in a fed-batch process (Fig. 26). The medium
contained a mixture of xylose, molasses and corn steep liquor, in order to reflect a
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Table 9: Growth and production physiology of C. glutamicum Xyl1 on chemically defined
medium with glucose or xylose as sole carbon source at 30 and 38 ◦C. The data are means
and standard deviations from three biological replicates and comprise maximal specific rates
of growth (µmax), substrate uptake (qS), lysine production (qP), and yields for biomass (YX/S)
and lysine (YP/S,molar, YP/S,C-molar).
Temperature Parameter Glucose Xylose
30 ◦C
µ [h-1 ] 0.20 ± 0.01 0.17 ± 0.01
qS [mmol g-1 h-1 ] 5.3 ± 0.3 5.7 ± 0.7
qP [mmol g-1 h-1 ] 1.5 ± 0.1 1.4 ± 0.1
YP/S,molar [mol mol-1 ] 0.35 ± 0.01 0.25 ± 0.01
YP/S,C-molar [C-mol C-mol-1 ] 0.35 ± 0.01 0.30 ± 0.01
YX/S [g g-1 ] 0.22 ± 0.00 0.19 ± 0.00
38 ◦C
µ [h-1 ] n/a 0.07 ± 0.00
YP/S,molar [mol mol-1 ] n/a 0.25 ± 0.01
YX/S [g g-1 ] n/a 0.07 ± 0.01
typical medium for industrial production. The process started with a batch phase
to achieve a fast increase in biomass concentration already in early process phases.
The initial mixture of 115 g L-1 total sugar (Fig. 26 A) contained mainly xylose (84
g L-1), plus smaller amounts of sucrose (13 g L-1), fructose (9 g L-1), and glucose (7
g L-1). During the first 20 h, cell and lysine concentration increased steeply, while
the sugar was rapidly utilized (Fig. 26 A). The maximum specific growth rate during
this phase was 0.09 h-1. Interestingly, C. glutamicum co-consumed all available
sugars, with preferential metabolization of the hexoses. As soon as the total sugar
had decreased to 25 g L-1, the feeding phase was started, during which the sugar
level remained around 30 g L-1. In the following 20 hours, the cell concentration
increased further, but leveled off after about 40 hours, when growth decreased to
a value that just compensated dilution of the medium by the addition of feed and
base. However, lysine accumulated further during the entire process. After about 120
hours of cultivation, the feed was stopped to allow metabolization of the residual
sugar. The final titer of lysine was 116 g L-1.
Dissolved oxygen (DO) was available in sufficient amounts throughout the whole
process (Fig. 26 B). Following a steep decline of the oxygen saturation in the
beginning of the cultivation, the lowest value of about 20 % coincided with the
near depletion of the hexose sugars. After that, the DO increased almost steadily,
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Fig. 26: Lysine production with C. glutamicum Xyl1 in a fed-batch process on xylose-based
medium containing industry-grade molasses. The dashed vertical line marks the start and
the end of the feed phase. The data points are means and deviations from two independent
experiments.
indicating a reduced activity in the oxygen-requiring biochemical reactions like the
energy metabolism. Ammonia concentration also remained at non-limiting levels at
least until the end of the feeding phase (Fig. 26 B). The Km value of the ammonia
transporter proteins in C. glutamicum is lower than 50 µM [137, 191]. Hence, the
concentrations present during the cultivation allowed for sufficient uptake.
Both, specific substrate uptake rate and product formation rate peaked during the
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Fig. 27: Lysine yield of C. glutamicum Xyl1 from fed-batch production on xylose-based
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initial batch phase and reached values of 0.17 g g-1 h-1 and 0.05 g g-1 h-1 respectively
(Fig. 26 C). The space-time yield reached a maximum of 1.5 g L-1 h-1 after 30
hours. During the first 90 hours, the lysine yield was constant at 0.38 g g-1 (0.39
C-mol C-mol-1 based on all sugars) and then dropped slightly, while the overall yield
was 0.36 g g-1 (Fig. 27).
For almost 40 years, lysine has been produced through fermentation from hexose
sugars. Throughout the years, the highly competitive lysine market has been a
major driver for continuous breeding of the major producer C. glutamicum towards
enhanced key performance indicators titer, yield and productivity [16]. Global
pathway engineering (systems metabolic engineering) has delivered optimized strains
for lysine production from traditional hexose-based substrates like starch, raw sugar
and molasses. Such globally engineered producers reach lysine titers of 120 g L-1
within 30 h of cultivation and carbon conversion yields of 0.55 g g-1 [18].
In the developing era of bio-based economy, strain engineering for lysine produc-
tion now expands to the utilization of alternative raw materials, particularly non-food
biomass such as lignocellulose and hemicellulose, most abundant in forestry and
agricultural residues [3] or in waste streams of the pulp and paper industry [130].
The application of systems metabolic engineering strategies to optimize C. glutami-
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Table 10: Performance of C. glutamicum strains (in [190] the closely related Brevibacterium
lactofermentum) for industrial lysine production. All studies used fed-batch processes for
production.
Major carbon source Complex ingredient Titer [g L-1 ] Ref.
Glucose Molasses 120 [18]
Glucose Molasses 105 [190]
Glucose - 90 [80]
Glucose - 80 [150]
Xylose Molasses 116 this work
cum for lysine production from a xylose-based medium proved very successful as the
novel strain C. glutamicum Xyl1 was capable of reaching a lysine titer of 116 g L-1
in a fed-batch process. Hereby, medium composition reflected that of large-scale
industrial cultivations, which often include cheap components such as molasses and
corn steep liquor [68]. The main carbon source was xylose, and the supplemented
molasses provided additional nutrients. Nitrogen for growth and lysine production
originated from corn steep liquor and ammonium.
So far, lysine titers above 100 g L-1 have been only reported for production from
glucose based media (Tab. 10), the preferred carbon source for C. glutamicum
and also most other microorganisms [80], so that the titer reached here keeps up
with reported benchmarks. Similarly, product yields of up to 0.38 g g-1 (Fig. 27)
lie well in the range of attractive production yields reported in the literature [72].
Together with recent studies, which demonstrate robustness of Corynebacteria against
inhibitors from hemicellulose hydrolysates [59] and access to an interesting product
portfolio from such raw materials [36, 138], this development sets an important
benchmark for hemicellulose biotechnology of C. glutamicum.
4.2.3 The engineered metabolism of C. glutamicum Xyl1 is tailored
for lysine production from xylose
Previous metabolic engineering of C. glutamicum for xylose assimilation focused
on local implementation of the xylose degradation pathway [97]. This probably
explains the lower performance of the resulting producers [138, 220], which did
not achieve the level required for industrial production. For lysine, none of the
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previously developed strains achieved economically attractive yields on xylose [138].
However, yield is a major criterion for the economic success of bulk products such
as lysine, for which the raw material is a major cost driver [41]. C. glutamicum
strain Xyl1 exhibits an overall yield of 0.39 C-mol C-mol-1. This value is 2.5 fold
higher than that obtained previously (Fig. 29). It is 52 % of the theoretical optimum
for the production of lysine from xylose (0.75 C-mol C-mol-1, 0.625 mol mol-1),
predicted by elementary flux mode analysis [34] and approaches the performance of
top lysine producers on conventional glucose-based raw materials (Fig. 29). The key
to this high performance is previous systems wide metabolic pathway engineering
(Fig. 28) with a set of 14 modifications. Hereby, the performance benefits from the
engineered core metabolism, specifically tailored for xylose-based through fluxome
and transcriptome based strain engineering [34]. Likewise, this combination of
targets enables high-yield production of diaminopentane from xylose (Fig. 29).
Accordingly, the genetic disposition of C. glutamicum Xyl1 is well suited for hyper-
production of different chemicals from xylose-based feedstocks.
4.2.4 Slower kinetics for lysine production from xylose as
compared to glucose leaves space for further strain
engineering
Xylose is less efficient than glucose with regard to space-time yield, i.e. productivity.
The maximum value of 1.5 glysine L-1 h-1 achieved (Fig. 26 C) is less than half of
the value of 4.0 g L-1 h-1 for production from glucose [18]. Without doubt, xylose
seems still attractive for production, considering the low price and high availability
of residues and waste materials containing xylose. However, this leaves space for
further improvement. C. glutamicum Xyl1 metabolizes xylose and glucose with
similar specific rates (Tab. 9), which indicates successful introduction of the xylose
operon. However, the influx of xylose in terms of carbon is only 5/6 of the value for
glucose, due to the smaller number of carbon atoms in the pentose sugar. Additionally,
growth on xylose results in lower growth rate and biomass yield, as compared to
glucose (Fig. 24, Fig. 25, Tab. 9).f Therefore, C. glutamicum Xyl1 could benefit
from further engineering of xylose utilization. Notably, the overexpression of the
Xanthomonas campestris xylose isomerase and of the C. glutamicum xylulokinase
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Fig. 28: Tailoring C. glutamicum Xyl1 for efficient lysine production from the hemicellulose
sugar xylose by systems-wide pathway engineering. Bold green arrows indicate reactions
with enhanced gene expression, bold dashed red arrows mark the reactions designed towards
reduced carbon flux. The modifications at the sites numbered 1 to 10 have been implemented
in previous work [11, 13, 18, 150] as mentioned in the chapter 2.1.6. The modifications
at the site 11 allow for xylose utilization in C. glutamicum Xyl1 presented in this work. 1:
PsodlysC, G1A, C932T; 2: 2×ddh; 3: ∆pck; 4: PsoddapB; 5: 2×lysA; 6: hom, T176C; 7: Psodpyc,
C1372T; 8: icd, A1G; 9: Ptuf fbp; 10: Psodtkt,tal,zwf,opcA,pgl; 11: pClik 5a MCS PgroxylAB.
Gene names (red italics) are listed on page vi.
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Fig. 29: Performance of lysine and diaminopentane producing C. glutamicum strains using
xylose (blue, solid bars) and glucose (green, hatched bar) as the main carbon source. The
yields given in darker colors represent experimentally achieved values. The yields given
in light colors represent the theoretical maxima, as deduced from in silico modeling by
elementary flux mode analysis. a: this work; b: estimated from reference [138]; c and d:
taken from reference [18] and [34], respectively.
provides improved growth rate and biomass yield in recombinant C. glutamicum
strains [138] and thus appears to be an interesting additional target for C. glutamicum
Xyl1. Indeed, the created producer possesses endogenous activity of xylulokinase
which could be enhanced by up-stream insertion of a strong promoter routinely
available for C. glutamicum [10].
Taken together, this work demonstrates high-titer production of lysine production
from a xylose-based industrial medium with C. glutamicum Xyl1, rationally engin-
eered for this purpose. The excellent performance of the recombinant C. glutamicum
strain on xylose, naturally not accessible by the bacterium, further opens the door
to hemicellulose raw materials and an even wider portfolio of processes of this
industrial workhorse beyond classical hexose-based biotechnology.
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4.3 Ectoine production by metabolically engineered C.
glutamicum
4.3.1 Re-design of C. glutamicum Lys1 for ectoine bio-synthesis
The metabolic production routes for lysine and ectoine both share the metabolite
aspartate-β-semialdehyde (ASA, Fig. 7 A and 9). The enzyme aspartokinase, generat-
ing its precursor, aspararatyl-phosphate, is under tight feedback control by threonine
and lysine in C. glutamicum ATCC 13032 [92]. Hence, for heterologous synthesis of
ectoine in C. glutamicum, the basic lysine-producer C. glutamicum Lys1 was chosen as
a suitable genetic background as it possesses a feedback-resistant aspartokinase [18]
and thereby circumvents the native biochemical pathway regulation for the synthesis
of ASA. Thus, an adequate supply of the precursor molecule for ectoine biosynthesis
(Fig. 9) was aimed for with the chosen starter strain C. glutamicum Lys1.
For the recombinant DNA experiments an ectABCD gene cluster from an isolate of
Pseudomonas stutzeri [240], a well-known ectoine and hydroxyectoine producer [186,
198], was chosen. To adjust the codon usage of the ectoine gene cluster employed
by the natural host strain P. stutzeri A1501 to that preferred by C. glutamicum, the
ectABCD genes were chemically synthesized and codon-optimized (sequence see Fig.
36 in the appendix). The expression of the naturally osmotically inducible operon
[198] was uncoupled from osmotic-stress-derived signal transduction processes by
positioning the synthetic ectABCD gene cluster under control of a strong and con-
stitutive C. glutamicum promoter that is driving the expression of the structural gene
(tuf) for the elongation factor Tu of C. glutamicum [13]. The resulting Ptu f ectABCD
construct was additionally provided at its 5’- and 3’-ends with regions flanking the
non-essential diaminopimelate dehydrogenase gene (ddh) for targeted integration
into the chromosome of C. glutamicum by a double-homologous recombination event
(Fig. 11). The ddh gene was chosen as integration site as it represents the more
active one of the two metabolic branches for the synthesis of lysine (Fig. 7) during
high availability of ammonium, which is usually the case during production processes
at industrial scale [48, 182]. The intention was to lower the carbon flux via this
pathway towards lysine to a priori diminish lysine formation as a major competitor
for the building block aspartate semialdehyde (Fig. 7 A and 9).
Successful integration and inactivation was verified by PCR analysis (Fig. 30, left
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Fig. 31: Specific diaminopimelate
dehydrogenase activity in the
strains C. glutamicum Lys1 and
Ect1.
gel) and determination of the Ddh activity (Fig. 31). The first showed the integration
of the 3448 bp long gene fragment (see Fig. 11) in the genome of C. glutamicum
Ect1 and the latter the absence of diaminopimelate dehydrogenase activity in the
strain due to the interruption of the ddh gene by said DNA fragment. In this way, a
recombinant strain C. glutamicum Ect1 was constructed that carried a single-copy
of the Ptu f ectABCD gene cluster stably integrated into a well-defined site in the
chromosome and that should be able to produce ectoine/hydroxyectoine in the
absence of osmotic stress.
4.3.2 C. glutamicum Ect1 efficiently produces ectoine from
glucose
Evaluation of the pattern and levels of ectoine/hydroxyectoine production in the
newly constructed C. glutamicum Ect1 strain was conducted by cultivation in a chem-
ically defined minimal medium with glucose as the carbon source. The experiment
revealed that the Ptu f ectABCD gene cluster was functionally expressed and that the
Ect1 strain produced and secreted ectoine in shake-flask cultures already from early
on (Fig. 32). Ectoine accumulated in the culture supernatant up to a final titer of
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Fig. 32: Cultivation profile of the heterologous ectoine producer strain C. glutamicum Ect1.
The C. glutamicum strain Ect1 was cultivated in shake flasks at 30 ◦C in a chemically defined
medium. At the indicated time intervals, consumption of glucose and the extracellular
accumulation of L-lysine, ectoine, and 5-hydroxyectoine were monitored. The data shown
represent mean values and corresponding standard deviations from three biological replicates.
1.3 mM, after the cells had completely depleted carbon source. About 2 % of the
consumed glucose was converted into ectoine as reflected by the molar yield of 19.4
mmol mol-1 (Tab. 11).
Hydroxyectoine was also detected in the culture supernatant, but at a rather low
concentration (< 0.1 mM). In addition to both compatible solutes, C. glutamicum
Ect1 secreted substantial amounts of L-lysine into the medium, 2.3 mM in total.
L-lysine production thus exceeded that of the desired products ectoine and hydroxy-
ectoine. Quantification of the intracellular levels of ectoine and hydroxyectoine
in C. glutamicum Ect1 revealed that ectoine accumulated up to 130 µmol gcdm-1
in the cytosol. Hydroxyectoine was detected in significantly lower amounts (ca.
5 µmol gcdm-1). Hence, relative amounts of these two compounds inside the cells
corresponded roughly to the production titers (Fig. 32).
4.3.3 Increased temperature positively affects production
The optimal cultivation temperature for the recombinant production of ectoine and
hydroxyectoine by C. glutamicum Ect1 was assessed by miniaturized cultivations
in a temperature range between 27 ◦C and 42 ◦C. Interestingly, this revealed that
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Fig. 33: Influence of cultivation temperature on the growth and ectoine production per-
formance of C. glutamicum Ect1. Strain Ect1 was grown in chemically defined medium with
glucose on a miniaturized scale at the indicated growth temperatures. The specific growth
rate µmax, ectoine secretion, and intracellular accumulation of ectoine and hydroxyectoine
were determined. Ectoines were quantified after 10 hours (27 ◦C– 35 ◦C) and 20 hours
(42 ◦C) of cultivation. The data shown represent mean values and corresponding standard
deviations from three biological replicates.
ectoine production was improved by increased temperature (Fig. 33). As compared
to the reference cultivation conditions for C. glutamicum Ect1 at 30 ◦C, secretion
was more than doubled when the temperature was set to 35 ◦C. The enhanced
production performance was also reflected by a slight increase of the intracellular
ectoine level. The higher cultivation temperature also positively influenced the
intracellular amounts of hydroxyectoine, and the growth performance of strain Ect1
as reflected by a 28 % increase of the specific growth rate (Fig. 33). The higher
ectoine concentration in the supernatant was taken as positive indication for a better
production performance at 35 ◦C.
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Table 11: Growth and production performance of C. glutamicum strains Lys1, Ect1 and Ect2
during batch cultivation on a mineral salt medium with glucose as carbon source at 30 ◦C
(Lys1, Ect1 & Ect2) and 35 ◦C (Ect2). The data represent mean values and standard deviations
from three biological replicates and denote specific rates for growth (µmax), substrate uptake
(qS) and product formation (qEct and qLys). Additionally, yields for biomass (YX/S), ectoine
(YEct/S), lysine (YLys/S), trehalose (YTre/S), α-ketoglutarate (YAKG/S) and hydroxyectoine
(YEctOH/S) are given. Data for C. glutamicum Lys1 are taken from previous work [18].
C. glutamicum strain Lys1 Ect1 Ect2 Ect2
Temperature 30 ◦C 30 ◦C 30 ◦C 35 ◦C
µmax [h-1] 0.38 ± 0.01 0.38 ± 0.01 0.38 ± 0.01 0.38 ± 0.01
qS [mmol g-1 h-1] 4.86 ± 0.10 3.82 ± 0.08 3.51 ± 0.05 3.74 ± 0.10
qEct [mmol g-1 h-1] n/a 0.07 ± 0.01 0.09 ± 0.01 0.12 ± 0.01
qLys [mmol g-1 h-1] 0.39 ± 0.02 0.20 ± 0.01 0.00 ± 0.00 0.00 ± 0.00
YX/S [g mol-1] 82.1 ± 1.3 87.2 ± 2.8 101.5 ± 0.6 90.9 ± 6.3
YEct/S [mmol mol-1] n/a 19.4 ± 1.5 24.6 ± 0.6 32.0 ± 0.8
YLys/S [mmol mol-1] 81.2 ± 3.2 53.8 ± 2.5 0.0 ± 0.0 0.0 ± 0.0
YTre/S [mmol mol-1] 9.4 ± 0.4 5.6 ± 0.1 7.2 ± 0.9 6.7 ± 0.2
YAKG/S [mmol mol-1] 0.0 ± 0.0 2.6 ± 0.4 1.0 ± 0.1 1.9 ± 0.1
YEctOH/S [mmol mol-1] n/a 0.6 ± 0.0 0.6 ± 0.0 0.9 ± 0.1
4.3.4 Elimination of lysine secretion generates a second
generation ectoine producer
Ectoine production of the first-generation producer Ect1 was limited by substantial
carbon loss related to L-lysine synthesis and subsequent secretion of this amino acid
into the growth medium. To avoid excretion of L-lysine, the gene (lysE) for the
L-lysine exporter LysE [216] was inactivated in the genetic background of strain
Ect1 to yield the second-generation ectoine producer C. glutamicum Ect2. Validation
was carried out by PCR (Fig. 30, right gel), confirming that a 575 bp segment
of the lysE gene was missing in C. glutamicum Ect2 compared to Ect1. First, the
novel C. glutamicum Ect2 strain was cultivated in shake flasks in glucose minimal
medium at 30 ◦C to allow a direct comparison of the performance with the parent
Ect1 strain. The deletion of the lysE gene had a beneficial influence on ectoine
production. As compared to the parent strain C. glutamicum Ect1, the molar ectoine
yield was increased by 27 % (Tab. 11). At the same time, L-lysine secretion was
completely eliminated. However, the additional carbon available for strain Ect2 was
not completely channeled towards ectoine production; it was instead recruited for
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biomass formation. To take benefit from the improved ectoine production at elevated
growth temperature observed for strain Ect1 (Fig. 33), the performance of strain
Ect2 at 35 ◦C was also investigated in greater detail.
Similarly to the C. glutamicum Ect1 strain, the higher growth temperature positively
influenced the production performance of the strain Ect2. The yield was increased
from 25 mmol mol-1 at 30 ◦C to 32 mmol mol-1 at 35 ◦C. When compared to the basic
proof-of-concept approach, the allover ectoine yield was improved in strain Ect2
by 65 %. In addition, strain Ect2 did not suffer from high fluxes to the by-product
L-lysine (Tab. 11). The specific growth rate of strain C. glutamicum Ect2 was hardly
affected by the elevated cultivation temperature (Tab. 11); however, the yield in
biomass was reduced, likely as a stress response of C. glutamicum to the increase in
growth temperature. This finding is different from the results presented in chapter
4.1 where it was shown that in addition to reduced biomass yields, C. glutamicum
strains Lys1, Lys12 and Lys12K also show lower specific growth rates. It is likely that
ectoine synthesized by C. glutamicum Ect2 acts as a compatible solute and enables
stable growth rates despite increased temperature. Taken together, the substantially
improved ectoine yield and the unaffected glucose uptake rate of strain Ect2 resulted
in an about 70 % increased specific productivity of the second-generation ectoine
producer C. glutamicum Ect2 (Tab. 11).
4.3.5 Ectoine synthesis affects the intracellular pools of amino
acids of the aspartate family
Aspartate semialdehyde is an important metabolite and critical branch point with
regard to biosynthesis of the aspartate family of amino acids [131]. Since ectoine
biosynthesis is dependent on a good supply of ASA as well (Fig. 9) [21, 198], the
intracellular pools of amino acids belonging to the aspartate family were examined.
Most desirable, integration of the synthetic ectoine cluster into the Ddh lysine branch
resulted in substantial decrease of the intracellular accumulation of lysine as major
by-product in the Ect1 strain (Tab. 12). This was taken as positive indication of a
successfully lowered carbon flux towards lysine biosynthesis, thus increasing the
ASA availability for the novel product ectoine. Ectoine indeed accumulated in sub-
stantially higher levels in the cytosol than lysine did (Tab. 12). Upon elimination of
the lysine exporter, however, the metabolite pattern completely changed. The novel
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Table 12: Concentration of free intracellular amino acids of the aspartate family and of
intracellular ectoine of the lysine producing strain C. glutamicum Lys1 and its ectoine
producing derivatives C. glutamicum Ect1 and Ect2. Cells were grown at 30 ◦C and 35 ◦C in
mineral salt medium. The data represent mean values with standard deviations from two
biological replicates, each sampled at three different optical densities (OD 2, OD 4 and OD
8).
Temperature Compound C. glutamicum
[µmol gcdw-1] Lys1 Ect1 Ect2
30 ◦C
Aspartate 11.8 ± 3.3 8.1 ± 2.9 7.0 ± 0.3
Asparagine 0.7 ± 0.3 24.6 ± 6.0 20.1 ± 4.9
Threonine 5.1 ± 0.9 3.9 ± 0.6 3.0 ± 0.9
Lysine 23.4 ± 3.1 14.5 ± 4.1 76.7 ± 11.3
Ectoine n/a 126.8 ± 25.5 34.1 ± 14.2
35 ◦C
Aspartate 9.1 ± 0.9 7.6 ± 0.6 7.9 ± 0.6
Asparagine 1.4 ± 0.2 28.1 ± 4.0 17.0 ± 2.4
Threonine 6.8 ± 0.5 6.5 ± 0.4 5.2 ± 0.4
Lysine 24.4 ± 6.3 16.3 ± 2.0 52.8 ± 12.6
Ectoine n/a 158.5 ± 20.7 36.1 ± 7.6
strain C. glutamicum Ect2 accumulated up to 77µmol gcdm-1 of lysine even exceeding
the value of the basic lysine producer C. glutamicum Lys1 more than three fold.
Simultaneously, the intracellular ectoine level dropped substantially (Tab. 12). Obvi-
ously, elimination of lysine secretion did not circumvent high carbon fluxes towards
this amino acid but resulted in increased intracellular accumulation. In addition to
the most obvious changes regarding the intracellular lysine and ectoine level, also
the formation of aspartate and threonine was slightly affected. As compared to the
parent lysine producer C. glutamicum Lys1, the cytosolic concentrations of these two
amino acids were slightly reduced in the synthetic ectoine cell factories. The intra-
cellular asparagine level, however, was strongly increased. Whereas only marginal
amounts were found in C. glutamicum Lys1, both Ect1 and Ect2 exhibited comparably
high intracellular asparagine levels, also competing with ectoine biosynthesis and
secretion. The cultivation temperature only had a marginal effect on the intracellular
amino acid accumulation. For ectoine, a slight trend towards higher accumulation
was observed at 35 ◦C as indicated by the miniaturized temperature screening.
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Fig. 34: Production performance of the advanced ectoine-producer C. glutamicum Ect2 during
fed-batch fermentation. During the batch phase, the oxygen saturation in the fermenter was
kept constant at 30 % by variation of the stirrer velocity and the aeration rate. Automated
feeding was initiated by a pO2-based signal [18]. Glucose concentration was thereby kept
below 5 g L-1. The data shown represent mean values from two independent fermentation
experiments.
4.3.6 Performance of the ectoine producing strain C. glutamicum
Ect2 under fed-batch conditions
To assess the overall production performance of C. glutamicum Ect2 under conditions
more relevant for an industrial process, the ectoine production by this strain was
benchmarked in a fed-batch process (Fig. 34). Ectoine was secreted from early on
during growth and accumulated in the growth medium to a final concentration of 4.5
g L-1 after 16 hours of fermentation. The production efficiency differed significantly
between the batch and the feeding phase of the process (Fig. 35). The initial 45 g L-1
glucose was already consumed after 8 hours and mainly served for the production of
biomass (Fig. 34). This was reflected by the rapid increase of the cell dry weight to
25 g L-1. As soon as the feeding was started, a shift in the production pattern towards
the formation of ectoine was observed. Overall, the feeding phase contributed to
more than 80 % of the total ectoine production (Fig. 34). The yield obtained during
the batch phase (28 mmol mol-1) was similar to the yield obtained during shake
flask cultivation of strain Ect2 (Tab. 11). In the feeding phase, however, it increased
10-fold up to about 300 mmol mol-1 (Fig. 35). This substantial increase provided an
overall space time yield of 6.7 g L-1 d-1 ectoine.
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Fig. 35: Ectoine yield achieved in the different cultivation phases during fed-batch fermenta-
tion (see Fig. 34) of the advanced ectoine-producer C. glutamicum Ect2. The data shown
represent mean values from two independent fermentation experiments.
4.3.7 C. glutamicum Ect2 enables decoupling of ectoine
production from high salinity in a marker-free host system
The stabilizing and function-preserving effects of ectoines have led to considerable
interests in these compounds and hence to the development of a variety of practical
applications [61, 124, 160]. As a consequence, ectoine and its derivative hydroxyec-
toine are considered as valuable natural microbial products and they have gained
significant market value in recent years. Their biotechnological production has
reached the scale of tons on an annual basis. The industrial production of ectoines is
currently achieved by bacterial milking of H. elongata [175, 184], a process that has
recently been improved by the inclusion of mutants of this bacterium that cannot
catabolize ectoines and those that accumulate these compounds in the high salinity
medium as a result of a defect in the ectoine/hydroxyectoine-specific TeaABC uptake
system [62].
The construction and characterization of a synthetic microbial cell factory for the
production of ectoine described here relies on the robust metabolism of C. glutamicum
[35, 226]. This bacterium incorporates features desirable for large scale production
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processes which are responsible for its tremendous rise and success as industrial
production host [15]. One of those beneficial features is the considerable knowledge
base for the genetic manipulation and large-scale fermentation processes of the
industrial workhorse C. glutamicum [15]. Most advantageous, the C. glutamicum
genome sequence lacks ectoine catabolic genes [93] eliminating product loss due to
the reuse of ectoine and hydroxyectoine as carbon or nitrogen sources – a drawback
of natural producer H. elongata [62]. In developing the synthetic C. glutamicum
ectoine cell factory several strategies were combined simultaneously to optimize its
production. Adaptation of the codon usage appeared promising as this strategy has
proven beneficial for the heterologous production of diaminopentane recruiting lysine
decarboxylase from E. coli [103]. Expression control via the constitutively active
tuf promoter of C. glutamicum [13, 103] not only decoupled ectABCD expression
from its natural osmo-stress responsive regulation [198], but also provided a simple
and robust promoter system with no specialized needs for the control of its activity.
Beyond this, the careful design of the cellular chassis guaranteed good supply of the
building block ASA which is normally tightly controlled in many microorganisms
including C. glutamicum [92, 131]. In addition, and in an effort to diminish carbon
flux towards L-lysine, the dehydrogenase branch of L-lysine biosynthesis [39, 194]
was inactivated.
In comparison to plasmid-based synthesis systems [172, 183, 186, 198] the strategy
presented here benefits from a stable genome-based integration of the synthetic
Ptu f ectABCD gene cluster (Fig. 11), an approach that has also been employed for
the recombinant production of ectoines by H. polymorpha [50]. Constitutive gene
expression in the synthetic C. glutamicum cell factory obviated the need for the
use of high salinity growth media, conditions that are typically required to trigger
enhanced expression of these genes in natural producers [33, 118, 119] such as H.
elongata [184]. The novel synthetic cell factory C. glutamicum Ect2 thus avoids the
considerable drawbacks of high salinity growth media during fermentation processes
that invoke corrosion problems on the reactor systems [172] and thereby drive up
the costs for their appropriate design and maintenance. Related to the economic
relevance, also previous studies have addressed the issue of a salt decoupled ectoine
production with the natural producers P. stutzeri and Chromohalobacter salexigens,
and the heterologous hosts H. polymorpha and E. coli [50, 172, 183, 186].
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4.3.8 Combined process and strain engineering increases ectoine
production in C. glutamicum
As successful proof of concept, the first generation C. glutamicum Ect1 strain revealed
salinity decoupled ectoine and hydroxyectoine production and secretion. Interest-
ingly, the summed molar yields of L-lysine and ectoine added up to 73.2 mmol mol-1,
a value that perfectly matches with the L-lysine yield of the parent strain C. glu-
tamicum Lys1 [18]. Hence, the carbon demand for ectoine synthesis seems to be
completely satisfied by the cells on the expense of L-lysine. Still, L-lysine production
dominated in the basic ectoine producer. This issue was addressed in a second round
of metabolic engineering through inactivation of the gene coding for the L-lysine
exporter LysE. This strategy has been applied for optimized diaminopentane produc-
tion by C. glutamicum [105]. Beyond the 27 % gain in ectoine yield (Tab. 11), the
inactivation of the lysine exporter avoided a contamination of the excreted ectoine,
a feature that will clearly facilitate the downstream processing for the recovery of
ectoine from the culture broth.
Further improved ectoine production was then achieved by an increase in the
growth temperature from 30 ◦C to 35 ◦C. In combination, genetic and process engin-
eering proved to be highly beneficial as reflected in a 65 % increased yield and a 70 %
increased specific productivity (Tab. 11). A rather unexpected finding of our study
was the observation that the recombinant strain produced so little hydroxyectoine
(Tab. 11). This is surprising because P. stutzeri A1501, on whose genetic blueprint
the synthetic ectABCD gene cluster is based, produces hydroxyectoine very efficiently
and in much greater quantities than ectoine [186, 198]. It is currently unclear why
there is so little hydroxyectoine formed by the C. glutamicum Ptu f ectABCD strains.
Overall, both recombinant C. glutamicum ectoine producers already performed ad-
mirably in shake-flask experiments. They exhibited excellent specific production
rates of 9.9 mg g-1 h-1 (C. glutamicum Ect1) and 17.1 mg g-1 h-1 (C. glutamicum
Ect2), thus exceeding that of the native and the heterologous ectoine production
hosts H. elongata (7.1 mg g-1 h-1) [175] and E. coli (2 mg g-1 h-1) [183]. However, a
closer examination of the achieved final yield of 32 mmol mol-1 revealed that it was
so far not possible to harness the complete carbon used by C. glutamicum Lys1 for
L-lysine synthesis for the recombinant production of ectoine.
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4.3.9 High-cell density fermentation reveals excellent production
performance
To take benefit from high cell densities [18, 154], which cannot readily be achieved
in shake-flask experiments, the performance of the second generation ectoine pro-
ducer C. glutamicum Ect2 was benchmarked under carefully controlled fed-batch
conditions. The ectoine production efficiency differed significantly during the batch
and the feeding phase of the fermentation process. That kind of desired shift in the
product spectrum is often intentionally induced at industrial scale production by
appropriate process operations. In general, this leads to an optimized channeling
of the substrate to the desired product within the feeding-phase [18, 34, 73, 123].
Similarly, a significant 10-fold increase of the ectoine yield in the feeding phase of
the C. glutamicum Ect2 fermentation (Fig. 35) could be observed. Though there was
detectable growth-associated ectoine production during the batch phase, the larger
fraction of ectoine seemed to be produced by cells during the feeding phase. The
achieved final titer of 4.5 g L-1 already approached to that of currently described
industrial production systems [53, 121, 212].
The excellent performance of the C. glutamicum strain Ect2 under fed-batch
conditions allowed the synthetic cell factory to achieve an overall space-time yield
of 6.7 g L-1 d-1 ectoine which is among the highest productivities reported so far in
the literature [53, 121, 212]. Better performance was, so far, only achieved with H.
boliviensis [212], and Chromohalobacter salexigens [53]. These do, however, rely on
high salinity and involve complex process operation strategies [53] thus driving up
the production costs.
4.3.10 Metabolic changes point at potential bottlenecks in ectoine
production
When introducing the synthetic ectoine gene cluster in lysine producing C. gluta-
micum Lys1, carbon flux within the cell was partly re-routed from the common
intermediate ASA to ectoine as indicated by the drop in extracellular and intracellu-
lar lysine ([18], Tab. 12), an effect equally observed at 30 ◦C and 35 ◦C. However,
elimination of lysine secretion resulted in a strong increase of the intracellular pool
of this amino acid. The additional carbon, now potentially elevating the ASA pool,
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was not efficiently recruited for driving ectoine biosynthesis. Obviously, the native
lysine route is still superior to the non-native route towards the novel product ectoine
despite the elimination of the dehydrogenase branch. In subsequent rounds of strain
engineering, this might be targeted by additional down-regulation of other lysine bio-
synthetic genes including dihydrodipicolinate synthase (dapB) and diaminopimelate
decarboxylase (lysA) previously identified as key reactions for lysine production [18].
In addition, manipulating the strength of the ribosome-binding sites of the various
ect genes might improve their expression. An additional issue involves the transport
processes related to the ectoine metabolism. Most favorable for production processes,
C. glutamicum excretes ectoine into the growth medium, a feature that was also
observed for other recombinant ectoine production systems [50, 183]. So far the
intracellular metabolite levels (Tab. 12) do not suggest limitations in the transport
processes but experience has shown that engineering the excretion systems for amino
acids and related compounds is beneficial for the performance of C. glutamicum
[16, 19, 31, 81, 105, 216]. In addition, it appears even more important to address
the uptake system of C. glutamicum comprising the three transporters EctP, LcoP,
and ProP [224]. In native producers, these transport systems not only serve for the
scavenging of stress protectants from natural resources [225], but they also function
as salvage systems to retrieve compatible solutes that leak or are actively released
from the producer cells [62, 63, 70]. As previously shown for the production of
aromatic amino acids [75, 76], the production efficiency of C. glutamicum might
significantly suffer from product re-uptake into the cell.
In addition, there is strong indication that the compatible solute transporter
TeaABC in H. elongata is integrated in the regulation of ectoine biosynthesis. De novo
biosynthesis of the cell is immediately decreased when externally supplied ectoine is
taken up via TeaABC [62]. As the regulatory mechanism is unknown so far, similar
regulation patterns involving the C. glutamicum ectoine transporters might also limit
the biosynthetic efficiency in the recombinant production host.
In contrast to the currently used H. elongata strain for the commercial production of
ectoines [124, 184] or other microbial species that have been suggested as alternative
natural producers [121, 178, 186, 198, 212], C. glutamicum has a long history for the
industry level production of valuable natural products by large-scale fermentation
procedures [68, 81]. Knowledge gained during the development of C. glutamicum
into an excellent performing microbial cell factory [17, 18, 34] can now be brought
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to bear in a scale-up process for ectoine production by the recombinant C. glutamicum
Ect2 strain. In addition, the ability to readily manipulate the genetic blueprint of
C. glutamicum on a genome-wide scale [18, 203, 208] will allow the application of
rational and systems-wide metabolic engineering approaches to further improve the
performance of the second generation ectoine producer C. glutamicum Ect2. The
success of these approaches has recently unequivocally been demonstrated in the
development of highly efficient L-lysine [18] and diaminopentane [34, 103, 104]
C. glutamicum cell factories.
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CONCLUSION AND OUTLOOK
Biotechnological production of chemicals will play an increasingly important role
in the global economy of the future to replace processes based on petrochemistry
[42]. In order to reach this goal, scientists and engineers have to integrate the
entire spectrum of biotechnological methods, ranging from molecular biology to
biochemical engineering and including analytical tools to gain an insight into intra-
and extracellular processes to precisely engineer them for the production of value
added chemicals.
C. glutamicum, a classical amino acid producer is a proven robust and versatile
production strain for a wide range of chemicals [15]. The results presented in this
work make use of the useful traits of C. glutamicum and show further improvements
in the substrate and product portfolio. Heterologous expression of genes from
Escherichia coli and Pseudomonas stutzeri allowed the utilization of xylose as a
substrate and the secretion of the compatible solute ectoine as a product, respectively.
The latter modification also included optimization of the genetic sequence for the
codon usage in C. glutamicum and utilization of a constitutive promoter. This allowed
the production of ectoine without the need for media of high salinity as the operon,
comprising the genes for ectoin production, is naturally under control of a promoter
triggered by osmotic stress. Thus the product portfolio of C. glutamicum could be
widened by a substance of interest for the cosmetic industry, while at the same time
making a simpler biotechnological production route for ectoine possible, which is
less destructive to the equipment than the bacterial milking processes applied for
natural producers [175, 184]. Further measures to increase the ectoin titer could
focus on the attenuation of lysine production to avoid the intracellular accumulation
of this amino acid. Additionally, genetic modifications that have proven useful for
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increasing lysine production [18, 150] could be implemented in C. glutamicum Ect2.
To focus purely on ectoine production, the gene cluster could be shortened by the
ectD gene to avoid hydroxyectoine co-production.
The implementation of the xylA and xylB genes from E. coli enabled conversion of
xylose to lysine, and integrated into an engineered core metabolism, enables lysine
titers above 100 g L-1 [138]. This is an important aspect for the industrial applicability,
for which final titer, yield and productivity are of utmost importance [41]. The
significance of xylose utilization for the production of valuable chemicals stems
from the need for alternative substrates for microbial processes. Those alternatives
must meet standards like non-competition with human nutrition. Xylose meets this
requirement and, a major building block of hemicellulose, has the benefit of being
globally available as a waste product in agriculture [3, 6, 202]. Further improvements
could be made to equip C. glutamicum Xyl1 with the genetic tools to utilize arabinose,
another pentose sugar present in hemicellulose, i.e. by transforming E. coli araBAD
genes. This approach has been successfully applied in C. glutamicum before [96,
179]. C. glutamicum Xyl1 could thus use hemicellulose hydrolysates more efficiently
for production of lysine [36].
In addition to the successful implementation on the molecular level, the effect of
temperature, an important factor in biotechnological production was investigated. It
was shown for a wide range of C. glutamicum strains, how cultivation at increased
temperature increases lysine yield. Through 13C flux analysis it was possible to
characterize the effect of the higher temperature on the metabolism of C. glutamicum.
This revealed a higher flux through the PP pathway and an increased net flux from
the phosphoenolpyruvate/pyruvate pool to the oxaloacetate/malate pool.
Interestingly, the effect of temperature, described above, was also observed for
C. glutamicum strains producing ectoine. It did, on the other hand, not occur
during lysine production on xylose. This underlines the importance of systems
wide knowledge about the production host, as such phenomena cannot be easily
understood. The increase in PP pathway carbon flux, observed during growth on
glucose at elevated temperature, hence might not take place on xylose.
To reach the aim of an economically feasible biotechnological production of chem-
icals, continuous improvement of existing systems and innovation for new routes
is necessary. The results presented in this work give clues on how to proceed. For
an improved lysine production from xylose, the carbon flux through the oxidative
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part of the PP pathway should be increased via molecular modification or maybe
co-feeding of a hexose sugar. The findings of the metabolic flux analysis at elevated
temperature suggest the PP pathway and the PEP/Pyr-OAA/Mal interconversion as
promising targets to further advance lysine production. Finally it becomes apparent
from the economic considerations presented in chapter 4.1.4 how important the
definition of a goal is for any attempt to optimization. In this example, the term
‘improved lysine production’ could mean either higher yields, higher titers or higher
productivity, but either of those possible goals requires a different approach.
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Ectoine synthese cluster nucleotide sequence
Gene_cluster_alingnment
 Section 1
1 4710 20 30(1) 
AGCGTATTCTCTGCAACTAGTGCATGTTGGATGCAATGGTTGCAGCGEctSC_codon_optimized (1) 
AGCGTATTCTCTGCAACTAGTGCATGTTGGATGCAATGGTTGCAGCGEctSC_native (1) 
 Section 2
48 9460 70 80(48) 
CCACTGAGCATCTTGGGAACCTCATGCATGAGCCGCAACACCATCTGEctSC_codon_optimized (48) 
CCACTGAGCATCTTGGGAACCTCATGCATGAGCCGCAACACCATCTGEctSC_native (48) 
 Section 3
95 141100 110 120 130(95) 
CCCACCGTTGGAATAGCCAACAATAAAGATCCTCTTGATGCCATACGEctSC_codon_optimized (95) 
CCCACCGTTGGAATAGCCAACAATAAAGATCCTCTTGATGCCATACGEctSC_native (95) 
 Section 4
142 188150 160 170(142) 
TGTTGCCCAAGTGCGTGGCGAGTTTTACAAAGAACCCCACATCATCAEctSC_codon_optimized (142) 
TGTTGCCCAAGTGCGTGGCGAGTTTTACAAAGAACCCCACATCATCAEctSC_native (142) 
 Section 5
189 235200 210 220(189) 
ATGCCTAAATGGCGGGTATTTTCATCCAAACCCAACCGCGCATCATTEctSC_codon_optimized (189) 
ATGCCTAAATGGCGGGTATTTTCATCCAAACCCAACCGCGCATCATTEctSC_native (189) 
 Section 6
236 282250 260 270(236) 
CCAATGCTGATCCACCCCATCCGGATAAACCACCATGAACGGCAACGEctSC_codon_optimized (236) 
CCAATGCTGATCCACCCCATCCGGATAAACCACCATGAACGGCAACGEctSC_native (236) 
 Section 7
283 329290 300 310(283) 
GATCAAAAGTCCTGTTGGTGAAGCTGCGCCCCACAGATCCTGACTGCEctSC_codon_optimized (283) 
GATCAAAAGTCCTGTTGGTGAAGCTGCGCCCCACAGATCCTGACTGCEctSC_native (283) 
 Section 8
330 376340 350 360(330) 
TGGGAGCCATGAAAATAGATCAGCGCATCCGTGGTGGAACCAAAAGGEctSC_codon_optimized (330) 
TGGGAGCCATGAAAATAGATCAGCGCATCCGTGGTGGAACCAAAAGGEctSC_native (330) 
 Section 9
377 423390 400 410(377) 
CTCAACAATACGAAACGTTCGCTTTCGGTCCTGATGAAAGAGATGTCEctSC_codon_optimized (377) 
CTCAACAATACGAAACGTTCGCTTTCGGTCCTGATGAAAGAGATGTCEctSC_native (377) 
Thursday, November 15, 2012 16:57:48 Page 1
Fig. 36: Nucleotide sequence of the ectoine gene cluster. The upper rows represent the
sequence optimized for gene expression in C. glutamicum. The lower rows show the native
Pseudomonas stutzeri sequence. (The sequence is continued on pages 97 to 101)
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	
	
	#
424 470430 440 450 460
CCTGAATCATCATCTAAGTATGCATCTCGGTAAGCTCGACCAGGACA		 
CCTGAATCATCATCTAAGTATGCATCTCGGTAAGCTCGACCAGGACA		 
	
471 517480 490 500"
GTGCCACCACAATTTTGGAGGATTACAAGAACATGACCAACATCCGC		 "
GTGCCACCACAATTTTGGAGGATTACAAGAACATGACCAACATCCGC		 "
	
518 564530 540 550 
GTAGCTATCGTGGGCTATCTAGAGTACCTGGGACGCAGCGTCGAAAA		  
GTAGCTATCGTGGGCTATCTAGAGTACCTGGGACGCAGCGTCGAAAA		  
	
565 611570 580 590 600 ! 
GTGGCCGTTACCCTGCGAATGTCCACAGGGTAGCTGGTAGTTTGAAA		  ! 
GTGGCCGTTACCCTGCGAATGTCCACAGGGTAGCTGGTAGTTTGAAA		  ! 
	
612 658620 630 640!
ATCAACGCCGTTGCCCTTAGGATTCAGTAACTGGCACATTTTGTAAT		 !
ATCAACGCCGTTGCCCTTAGGATTCAGTAACTGGCACATTTTGTAAT		 !
	 
659 705670 680 690! 
GCGCTAGATCTGTGTGCTCAGTCTTCCAGGCTGCTTATCACAGTGAA		 ! 
GCGCTAGATCTGTGTGCTCAGTCTTCCAGGCTGCTTATCACAGTGAA		 ! 
	!
706 752720 730 740"#!
AGCAAAACCAATTCGTGGCTGCGAAAGTCGTAGCCACCACGAAGTCC		 "#!
AGCAAAACCAATTCGTGGCTGCGAAAGTCGTAGCCACCACGAAGTCC		 "#!
	"
753 799760 770 780" 
AGGAGGACATACAATGCCAACCCTGAAGCGCAACTCCATCAACAACC		 " 
AGGAGGACATACAATGCCTACCCTAAAAAGGAATTCAATCAACAACC		 " 
	
800 846810 820 830##
CAAAGGGCATCGTGCTGTCCTTCCCAACCGTGATGCTGCGTCGCCCA		 ##
CCAAAGGCATTGTTTTGAGTTTCCCCACCGTAATGCTCCGTCGCCCA		 ##
$%
&'()
 '#!* "*+
	
	
	
847 893860 870 880"
ACCGATGGCGACGGCTACAACCTGCACCAGCTCGTGGCACGCTGCCA		 "
ACCGACGGCGACGGTTACAACCTTCATCAGCTGGTGGCGCGCTGCCA		 "
	#
894 940900 910 920 930
GCCACTGGATACCAACTCCGTGTACTGCAACCTGCTGCAGTGCTCCG		 
GCCCCTCGATACCAATTCGGTCTACTGCAACCTGCTGCAGTGTTCCG		 
	
941 987950 960 970
ATTTCGCAGATACCGCAATCGCAGCAGAAAACGCACAGGGCGAACTG		 
ATTTCGCTGACACCGCCATCGCCGCAGAGAACGCCCAAGGCGAGCTG		 
	
988 10341000 1010 1020
GTGGGCTTCATCTCCGGCTACCGTCCACCATCCCGTCCAGATACCCT		 
GTCGGTTTCATCTCGGGTTACCGCCCCCCTTCGCGGCCGGACACGCT		 
	
1035 10811040 1050 1060 1070# 
GTTCGTGTGGCAGGTCGCAGTGGATTCCTCCATGCGTGGCCAGGGCC		 # 
GTTCGTCTGGCAGGTCGCCGTCGACAGTTCGATGCGCGGTCAGGGGC		 # 
	
1082 11281090 1100 1110#
TGGCACTGCGCATGCTGCTGGCACTGACCGCACGCGTGGCACGCGAA		 #
TGGCCCTGCGCATGCTGCTGGCACTGACCGCCCGGGTCGCTCGCGAG		 #
	 
1129 11751140 1150 1160
TACGGCGTGCGCTACATGGAAACCACCATCTCCCCAGATAACGGTGC		 
TACGGCGTGCGTTACATGGAAACCACCATCTCGCCGGACAACGGGGC		 
	!
1176 12221190 1200 1210"!
ATCCCAGGCACTGTTCAAACGCGCATTCGATCGCCTGGATGCAAACT		 "!
GTCACAGGCGCTGTTCAAGCGGGCCTTCGACCGCCTCGATGCCAACT		 "!
	"
1223 12691230 1240 1250
GCACCACCCGCACCCTGTTCGCACGCGATACCCACTTCGCAGGCCAG		 
GCACGACGCGCACGCTGTTTGCCCGCGACACGCATTTCGCCGGTCAG		 
$%
&'()
 '#!* "*+
Fig. 36: Ectoine nucleotide sequence. (Continued from page 96).
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	
	
	
1270 13161280 1290 1300"#
CACGAAGATGAAGTGCTGTACCGTGCAGGCCCATTCACCGTGTCCCA		 "#
CACGAGGACGAGGTGCTCTACCGCGCCGGCCCGTTCACCGTTTCCCA		 "#
	
1317 13631330 1340 1350"
CCTGGAAGAAGAACTGAAAGAACACGCATAAGAAGTCCAGGAGGACA		 "
TCTAGAAGAAGAGCTCAAGGAGCACGCATGAGAAGTCCAGGAGGACA		 "
	#
1364 14101370 1380 1390 1400!
TACAATGAAAACCTTCGAACTGAACGAATCCCGTGTGCGCTCCTACT		 !
TACAATGAAAACTTTTGAACTGAATGAATCCAGGGTTCGCAGCTACT		 !
	
1411 14571420 1430 1440
GCCGCTCCTTCCCAGTGGTGTTCAAGCAGGCACAGGGTGCAGAACTG		 
GCCGTTCCTTCCCCGTGGTCTTCAAGCAGGCCCAGGGCGCCGAACTG		 
	
1458 15041470 1480 1490 
GTGACCCAGGATGGCAAGCGCTACATCGATTTCTTGGCAGGCGCAGG		  
GTCACTCAGGACGGCAAGCGCTACATCGACTTCCTCGCTGGTGCCGG		  
	
1505 15511510 1520 1530 1540 # 
CACCCTGAACTACGGCCACAACCACCCAGTGCTGAAGCAGGCACTGC		  # 
CACGCTCAACTACGGGCACAACCACCCGGTGCTCAAGCAGGCGCTGC		  # 
	
1552 15981560 1570 1580  
TGGAATACATCGAATCCGATGGCATCACCCACGGCCTGGATATGTAC		   
TCGAGTACATCGAGAGCGACGGCATCACCCACGGCCTGGACATGTAC		   
	 
1599 16451610 1620 1630 
ACCGAAGCAAAAGAACGCTTCCTGGAAACCTTCAACCGCCTGATCCT		  
ACCGAAGCCAAGGAGCGTTTCCTCGAAACCTTCAACCGGCTGATCCT		  
	!
1646 16921660 1670 1680!!
GGAACCACGCGGTATGGGCGATTACCGCATGCAGTTCACCGGTCCAA		 !!
CGAGCCGCGCGGCATGGGCGACTACCGCATGCAGTTCACCGGCCCGA		 !!
$%
&'()
 '#!* "*+
	
	
	"
1693 17391700 1710 1720!
CCGGCACCAACGCAGTGGAAGCAGCAATGAAGCTGGCACGCAAGGTG		 !
CCGGCACCAACGCGGTCGAGGCGGCGATGAAGCTGGCGCGCAAGGTC		 !
	
1740 17861750 1760 1770"#
ACCGGTCGCAACAACATCATTTCCTTCACCAACGGCTTCCACGGCTG		 "#
ACCGGGCGCAACAACATCATCAGTTTCACCAACGGCTTCCACGGCTG		 "#
	
1787 18331800 1810 1820""
CTCCATCGGTGCACTGGCAGCAACCGGCAACCAGCACCACCGTGGCG		 ""
CAGCATTGGCGCGCTGGCCGCCACCGGCAACCAGCATCACCGCGGCG		 ""
	#
1834 18801840 1850 1860 1870
GTTCCGGCATCGGCCTGACCGATGTGTCCCGCATGCCATACGCAAAC		 
GCTCCGGCATCGGCCTCACCGATGTCAGCCGCATGCCGTACGCCAAC		 
	
1881 19271890 1900 1910
TACTTCGGCGATAAGACCAACACCATCGGCATGATGGATAAGCTGCT		 
TATTTCGGCGACAAGACCAACACCATCGGCATGATGGACAAGCTGCT		 
	
1928 19741940 1950 1960
GTCCGATCCATCCTCCGGCATCGATAAGCCAGCAGCAGTGATCGTGG		 
CTCCGACCCGTCCAGCGGGATCGACAAGCCCGCCGCGGTGATCGTCG		 
	
1975 20211980 1990 2000 2010" 
AAGTGGTGCAGGGCGAAGGCGGTCTGAACACCGCATCCGCAGAATGG		 " 
AGGTGGTCCAGGGCGAAGGCGGTCTGAACACAGCATCGGCCGAGTGG		 " 
	
2022 20682030 2040 2050#
ATGCGCAAGCTGGAAAAGCTGTGCCGCAAGCACGAAATGCTGCTGAT		 #
ATGCGCAAGCTCGAGAAGCTCTGCCGCAAGCACGAGATGCTGCTGAT		 #
	 
2069 21152080 2090 2100#!
CGTGGATGATATCCAGGCAGGCTGCGGTCGTACCGGTACCTTCTTCT		 #!
CGTCGATGACATCCAGGCCGGCTGCGGCCGCACCGGGACTTTCTTCA		 #!
$%
&'()
 '#!* "*+ 
Fig. 36: Ectoine nucleotide sequence. (Continued from page 97).
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	
	!
2116 21622130 2140 2150!
CCTTCGAAGAAATGGGCATCCAGCCAGATATCGTGACCCTGTCCAAG		 !
GCTTCGAAGAGATGGGCATCCAGCCGGATATCGTCACGCTGTCCAAG		 !
	"
2163 22092170 2180 2190!
TCCCTGTCCGGCTACGGCCTGCCATTCGCAATGGTGCTGCTGCGCCA		 !
TCGCTGTCCGGCTACGGCCTGCCGTTCGCCATGGTGTTGCTGCGCCA		 !
	
2210 22562220 2230 2240#
AGAACTGGATCAGTGGAAGCCAGGCGAACACAACGGCACCTTCCGTG		 #
AGAGCTGGACCAGTGGAAGCCCGGCGAACACAACGGCACCTTCCGCG		 #
	
2257 23032270 2280 2290 "
GCAACAACCACGCATTCGTGACCGCAGCAGCAGCAGTGGAACACTTC		  "
GCAACAACCATGCATTCGTCACGGCGGCCGCGGCGGTCGAGCACTTC		  "
	 #
2304 23502310 2320 2330 2340#
TGGCAGAACGATGCATTCGCAAACTCCGTGAAGGCAAAGGGCAAGCG		 #
TGGCAGAACGACGCGTTCGCCAACAGCGTGAAGGCCAAGGGCAAGCG		 #
	 
2351 23972360 2370 2380 
CATTGCAGATGGCATGCAGCGCATCATCCGTCGCCACGGTCCAGACT		  
CATCGCCGACGGCATGCAGCGCATCATCCGTCGCCACGGCCCGGATT		  
	 
2398 24442410 2420 2430
CCCTGTTCCTGAAGGGTCGCGGTATGATGATCGGCATCTCCTGCCCA		 
CGCTGTTCCTCAAGGGCCGCGGGATGATGATCGGCATCAGCTGCCCC		 
	 
2445 24912450 2460 2470 2480 
GATGGCGAAATCGCAGCAGCCGTGTGTCGCCACGCATTCGAAAACGG		  
GATGGCGAGATTGCCGCCGCAGTGTGCCGCCACGCCTTCGAAAACGG		  
	 
2492 25382500 2510 2520
CCTGGTGATCGAAACCTCCGGTGCACACTCCGAAGTGGTGAAGTGCC		 
CCTGGTGATCGAGACCAGCGGCGCCCACAGCGAAGTGGTCAAGTGCC		 
$%
&'()
 '#!* "*+!
	
	
	  
2539 25852550 2560 2570 
TGTGCCCACTGATCATCTCCGATGAGCAGATCGATCAGGCACTGTCC		  
TCTGCCCGCTGATCATCAGCGATGAGCAGATCGACCAGGCACTTTCC		  
	 !
2586 26322600 2610 2620 !
ATCCTGGATAAGGCATTCGCAGCAGTGATGTCCGAACAGACCGAAAA		  !
ATCCTCGACAAGGCCTTTGCCGCCGTGATGAGCGAGCAGACCGAGAA		  !
	 "
2633 26792640 2650 2660!
CCAGGCATCCTAAGAAGTCCAGGAGGACATACAATGATCGTGCGCAC		 !
CCAAGCTTCCTAAGAAGTCCAGGAGGACATACAATGATCGTCAGAAC		 !
	 
2680 27262690 2700 2710!#
CCTGGCAGAATGCGAAAAGACCGATCGCAAGGTGCACTCCCAGACCG		 !#
CCTCGCCGAGTGCGAAAAGACCGACCGCAAGGTCCACAGCCAGACCG		 !#
	 
2727 27732740 2750 2760""
GCACCTGGGATTCCACCCGCATGCTGCTCAAGGATGATAAGGTGGGC		 ""
GCACCTGGGACAGCACGCGCATGCTGCTCAAGGACGACAAGGTGGGA		 ""
	!#
2774 28202780 2790 2800 2810""
TTCTCCTTCCACATCACCACCATCTACGCAGGCTCCGAAACCCACAT		 ""
TTCTCCTTCCACATCACCACCATCTACGCCGGCAGCGAGACGCACAT		 ""
	!
2821 28672830 2840 2850
CCACTACCAGAACCACTTCGAATCCGTCTACTGCATCTCCGGCAACG		 
CCACTACCAGAACCACTTCGAGTCGGTGTACTGCATCAGCGGCAATG		 
	!
2868 29142880 2890 2900!
GCGAAATCGAAACCATTGCCGATGGCAAGATCTACAAGATCGAACCA		 !
GCGAGATCGAAACCATCGCCGACGGCAAGATCTACAAGATCGAGCCG		 !
	!
2915 29612920 2930 2940 2950 
GGCACCCTGTACGTGCTGGAAAAGCACGATGAACACCTGTTGCGTGG		  
GGCACGCTGTACGTGCTGGAGAAGCATGACGAGCACCTGCTGCGCGG		  
$%
&'()
 '#!* "*+"
Fig. 36: Ectoine nucleotide sequence. (Continued from page 98).
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	
	
	!
2962 30082970 2980 2990!
TGGCTCCGAAGATATGAAGCTGGCCTGCGTGTTCAACCCACCACTGA		 !
TGGCAGCGAAGACATGAAGCTGGCCTGCGTCTTCAACCCGCCGCTCA		 !
	! 
3009 30553020 3030 3040##
ACGGTCGCGAAGTGCACGATGAATCCGGTGTGTACCCACTGGAAGCA		 ##
ACGGGCGCGAAGTGCATGACGAAAGCGGCGTCTATCCTCTGGAGGCC		 ##
	!!
3056 31023070 3080 3090# !
GAAACCGTGTAATACCGGAGCTCGATCACGAAGTCCAGGAGGACATA		 # !
GAAACCGTCTGATACCGGAGCTCGATCACGAAGTCCAGGAGGACATA		 # !
	!"
3103 31493110 3120 3130#
CAATGCAGGCAGATCTGTACCCATCCCGTCAAGAAGATCAGCCATCC		 #
CAATGCAAGCCGACCTGTATCCCTCGCGCCAGGAAGACCAGCCCAGC		 #
	!
3150 31963160 3170 3180 #
TGGCAAGAACGCCTGGATCCAGTGGTGTACCGCTCCGATCTGGAAAA		  #
TGGCAGGAACGCCTGGATCCGGTCGTCTACCGCAGCGACCTGGAGAA		  #
	!
3197 32433210 3220 3230"
CGCACCAATCGCAGCCGAACTGGTGGAACGCTTCGAACGCGACGGCT		 "
TGCGCCGATCGCGGCAGAGCTGGTCGAACGCTTCGAACGCGACGGCT		 "
	"#
3244 32903250 3260 3270 3280
ACCTGGTGATCCCAAACCTGTTCTCCGCAGATGAAGTGGCACTGTTT		 
ACCTGGTCATCCCCAATCTGTTCAGCGCCGACGAAGTCGCGCTGTTT		 
	"
3291 33373300 3310 3320
CGCGCAGAACTGGAACGCATGCGCCAGGATCCAGCAGTGGCAGGCTC		 
CGCGCCGAACTCGAGCGCATGCGCCAGGACCCGGCCGTCGCCGGTTC		 
	"
3338 33843350 3360 3370
CGGCAAGACCATCAAAGAACCAGATTCCGGTGCAATCCGCTCCGTGT		 
CGGCAAGACCATCAAGGAACCCGACAGCGGTGCGATCCGCTCGGTGT		 
$%
&'()
 '#!* "*+
	
	
	"
3385 34313390 3400 3410 3420 
TCGCAATCCACAAGGATAACGAACTGTTCGCTCGCGTGGCAGCAGAT		  
TCGCCATCCACAAGGACAACGAGCTGTTCGCCCGCGTCGCAGCCGAC		  
	"
3432 34783440 3450 3460
GAACGCACCGCAGGTATCGCACGCTTCATCCTGGGTGGCGATCTGTA		 
GAGCGCACCGCCGGCATCGCCCGCTTCATCCTTGGCGGCGACCTGTA		 
	" 
3479 35253490 3500 3510"
CGTGCACCAGTCCCGCATGAACTTCAAGCCAGGCTTCACCGGCAAAG		 "
CGTGCATCAGTCGCGAATGAACTTCAAGCCCGGCTTCACCGGCAAGG		 "
	"!
3526 35723540 3550 3560 !
AATTCTACTGGCACTCCGATTTCGAAACCTGGCACATCGAAGATGGC		  !
AGTTCTACTGGCACTCGGATTTCGAGACCTGGCACATCGAGGACGGC		  !
	""
3573 36193580 3590 3600 "
ATGCCACGCATGCGCTGCCTGTCCTGCTCCATCCTGCTGACCGATAA		  "
ATGCCGCGCATGCGCTGCCTGTCCTGCTCGATCCTCTTGACCGACAA		  "
	"
3620 36663630 3640 3650!#
CGAACCACACAACGGTCCACTGATGCTGATGCCAGGCTCCCACAAGC		 !#
CGAGCCGCACAACGGCCCGCTGATGCTGATGCCCGGCTCGCACAAGC		 !#
	"
3667 37133680 3690 3700!!"
ACTACGTGCGCTGCGTTGGCGCAACCCCAGAAAACCACTACGAAAAG		 !!"
ACTACGTGCGCTGCGTCGGAGCCACACCGGAAAATCACTACGAGAAG		 !!"
	#
3714 37603720 3730 3740 3750"
TCCCTGCGCAAGCAAGAAATCGGCATCCCTGATCAGAACTCCCTGTC		 "
TCCCTGCGCAAGCAGGAGATCGGCATCCCCGACCAGAACAGCCTGAG		 "
	
3761 38073770 3780 3790"!
CGAACTGGCATCCCGCTTCGGCATCGATTGCGCAACCGGTCCAGCAG		 "!
CGAGCTGGCCAGCCGCTTCGGCATCGACTGCGCCACCGGCCCCGCCG		 "!
$%
&'()
 '#!* "*+
Fig. 36: Ectoine nucleotide sequence. (Continued from page 99).
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	
	
	
3808 38543820 3830 3840#
GCTCCGTGGTGTTCTTCGATTGCAACACCATGCACGGCTCCAACGGC		 #
GCAGCGTGGTGTTCTTCGACTGCAACACCATGCACGGCTCCAACGGC		 #
	
3855 39013860 3870 3880 3890  
AACATCACCCCATCCGCACGCTCCAACCTGTTCTACGTGTACAACCA		   
AACATCACGCCCAGCGCGCGTAGCAATCTGTTCTACGTCTACAACCA		   
	
3902 39483910 3920 3930#
CGTGGATAACGCAGTGCAGGCACCATTCTGCGAACAGAAGCCACGCC		 #
CGTGGATAATGCCGTGCAGGCTCCGTTCTGCGAGCAGAAACCGCGCC		 #
	 
3949 39953960 3970 3980
CAGCATTCGTGGCCGAACGCGAAAACTTCAAGCCTCTGGATATTCGC		 
CGGCCTTTGTCGCCGAACGCGAGAATTTCAAGCCGCTGGACATTCGG		 
	!
3996 40424010 4020 4030!
CCACAGCAGTACCTGTAATCCAGGATCCATACCTGCTCTCCCCAGAG		 !
CCGCAACAGTATCTCTGATCCAGGATCCATACCTGCTCTCCCCAGAG		 !
	"
4043 40894050 4060 4070#
AATCTAGAGTACCGATCTGATCGCACGCGACGTCTAATTTAGCTCGA		 #
AATCTAGAGTACCGATCTGATCGCACGCGACGTCTAATTTAGCTCGA		 #
	
4090 41364100 4110 4120##
GGGGCAAGGAAACAGTGTGGTTTCCTTGCCTCTTTTAGCCTTTTCAG		 ##
GGGGCAAGGAAACAGTGTGGTTTCCTTGCCTCTTTTAGCCTTTTCAG		 ##
	
4137 41834150 4160 4170"
AGGGTGTCTTCGCTGGACCAAGAGGAAACCAGACAGGCGTGACAAAA		 "
AGGGTGTCTTCGCTGGACCAAGAGGAAACCAGACAGGCGTGACAAAA		 "
	#
4184 42304190 4200 4210 4220
ATCTGGATTTCCGCCAGGTTTTGGCACGCCTGTCTGGTTTAGGGGAT		 
ATCTGGATTTCCGCCAGGTTTTGGCACGCCTGTCTGGTTTAGGGGAT		 
$%
&'()
 '#!* "*+#
	
	
	
4231 42774240 4250 4260
GAGAAACCGGACACACGTGCCAAAACTTCGGCTTTTTCGCCAATCTT		 
GAGAAACCGGACACACGTGCCAAAACTTCGGCTTTTTCGCCAATCTT		 
	
4278 43244290 4300 4310"
GTCACGCCTGTCTGGTTTGCCTCGGATGAGGTGATTTCATGGCCAAG		 "
GTCACGCCTGTCTGGTTTGCCTCGGATGAGGTGATTTCATGGCCAAG		 "
	
4325 43714330 4340 4350 4360 
ACTTCTAAAAGTTCGACCTCGCAGGATCGCTTCTAAGGGCCTTTAGC		  
ACTTCTAAAAGTTCGACCTCGCAGGATCGCTTCTAAGGGCCTTTAGC		  
	
4372 44184380 4390 4400"
GGACCAACCTAGGCCGATACCCATGTGGAAATCTCGACGTCTTAAAT		 "
GGACCAACCTAGGCCGATACCCATGTGGAAATCTCGACGTCTTAAAT		 "
	 
4419 44654430 4440 4450
GGACGATTGGAGCTAAAACCACGAACAGCTGGGATTTTCCACGATAG		 
GGACGATTGGAGCTAAAACCACGAACAGCTGGGATTTTCCACGATAG		 
	!
4466 45124480 4490 4500!!
GATTGGGTCTCGTGGAGATTCGTTGGTTGGAAGGCTTTATCGCGGTC		 !!
GATTGGGTCTCGTGGAGATTCGTTGGTTGGAAGGCTTTATCGCGGTC		 !!
	"
4513 45594520 4530 4540 
GCGGAAGAATTGCACTAGTAATGCTGCGATTCGTTTGGGGATGCCGC		  
GCGGAAGAATTGCACTAGTAATGCTGCGATTCGTTTGGGGATGCCGC		  
	
4560 4577 !#
AATCGCCGTTGAGTCAGT		  !#
AATCGCCGTTGAGTCAGT		  !#
$%
&'()
 '#!* "*+
Fig. 36: Ectoine nucleotide sequence. (Continued from page 100).
99
Appendix
3 
 
Supplementary Table S II: Reprogramming of the OpenFlux 25 
subroutine files “leastSQ.m” and “mdvGenerator” for comprehensive 26 
integration of two parallel 13C-labeling experiments. 27 
leastSQ  
original modified 
%%to load input substrate MDV 
global guidedInSub 
if isempty(guidedInSub) || 
guidedInSub == 0 
    substrate_EMU 
else 
    load inputSubEMU 
end 
  
 
%%load rates 
v = - fluxCalc(u); 
v(find(abs(v)<1e-8))=0; 
v = appendSyn(v,u); 
  
loader_EMUModel 
 
 
 
 
EMUModel 
  
x_sim 
 
%%to load input substrate MDV 
global guidedInSub 
if isempty(guidedInSub) || guidedInSub 
== 0 
    substrate_EMU 
else 
    load inputSubEMU_exp1 
    load inputSubEMU_exp2 
 end 
  
%%load rates 
v = - fluxCalc(u); 
v(find(abs(v)<1e-8))=0; 
v = appendSyn(v,u); 
  
loader_EMUModel 
 
x_calc_big=[]; 
load inputSubEMU_exp1 
 
EMUModel 
  
x_sim 
x_calc_big=[x_calc]; 
  
load inputSubEMU_exp2 
EMUModel 
x_sim 
x_calc_big=[x_calc_big; x_calc]; 
  
x_calc = x_calc_big;  
mdvGenerator  
original modified 
a = dir(fullfile(pwd,'*.mat')); 
AAVFile = 0; 
 
for i = 1:length(a) 
    if strcmp(a(i).name, 
'inputSubEMU.mat') 
        AAVFile = 1; 
    end 
end 
 
 
 
 
if AAVFile ==1; 
    load inputSubEMU.mat 
 
else 
   substrate_EMU; 
end 
 loader_EMUModel 
 
 
 
 
 
 
 
 
 
EMUModel 
x_sim 
 
 
mdvOut = x_calc; 
a = dir(fullfile(pwd,'*.mat')); 
AAVFile = 0; 
AAVFile_2 = 0; 
for i = 1:length(a) 
    if strcmp(a(i).name, 
'inputSubEMU_exp1.mat') 
        AAVFile = 1; 
    end     
    if strcmp(a(i).name, 
'inputSubEMU_exp2.mat') 
        AAVFile_2 = 1;    
    end 
end 
if (AAVFile == 1) && (AAVFile_2 == 1); 
    load inputSubEMU_exp1.mat 
    load inputSubEMU_exp2.mat 
else 
   substrate_EMU; 
end 
  
loader_EMUModel 
 x_calc_big=[]; 
  
load inputSubEMU_exp1 
EMUModel 
x_sim 
x_calc_big=[x_calc]; 
  
load inputSubEMU_exp2 
EMUModel 
x_sim 
x_calc_big=[ x_calc_big; x_calc]; 
x_calc = x_calc_big; 
mdvOut = x_calc; 
Fig. 37: Reprogramming of the OpenFlux subroutine files ‘leastSQ.m’ and ‘mdvGenerator’
for comprehensive integration of two parallel 13C-labeling experiments.
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